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ABSTRACT OF THE DISSERTATION
FOLDING OF BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) IS FASTER
USING AROMATIC THIOLS AND THEIR CORRESPONDING DISULFIDES
by
Ram Prasad Marahatta
Florida International University, 2017
Miami, Florida
Professor Watson J. Lees, Major Professor
Improvement in the in vitro oxidative folding of disulfide containing
proteins, such as extracellular and pharmaceutically important proteins, is
required. Traditional folding methods using small molecule aliphatic thiol and
disulfide, such as glutathione (GSH) and glutathione disulfide (GSSG) are slow
and low yielding. Small molecule aromatic thiols and disulfides show great
potentiality because aromatic thiols have low pKa values, close to the thiol pKa of
protein disulfide isomerase (PDI), higher nucleophilicity and good leaving group
ability. Our studies showed that thiols with positively charged group, quaternary
ammonium salts (QAS), are better than thiols with negatively charged groups
such as phosphonic acid and sulfonic acid for the folding of bovine pancreatic
trypsin inhibitor (BPTI). An enhanced folding rate of BPTI was observed when the
protein was folded with a redox buffer composed of a QAS thiol and its
corresponding disulfide.
Quaternary ammonium salt (QAS) thiols and their corresponding disulfides
with longer alkyl side chains were synthesized. These QAS thiols and their

vi

corresponding disulfides are promising small molecule thiols and disulfides to
fold reduced BPTI efficiently because these thiols are more hydrophobic and can
enter the core of the protein.
Conformational changes of disulfide containing proteins during oxidative
folding influence the folding pathway greatly. We performed the folding of BPTI
using

targeted

molecular

dynamics

(TMD)

simulation

and

investigated

conformational changes along with the folding pathway. Applying a bias force to
all atoms versus to only alpha carbons and the sulfur of cysteines showed
different folding pathways. The formation of kinetic traps N' and N* were not
observed during our simulation applying bias force to all atoms of the starting
structure. The final native conformation was obtained once the correct
antiparallel β-sheets and subsequent Cys14-Cys38 distance was decreased to a
bond distance level. When bias force was applied to only alpha carbons and the
sulfur of cysteines, the distance between Cys14-Cys38 increased and decreased
multiple times, structure similar to the conformation of N*, NSH were formed and
native protein was ultimately obtained. We concluded that there could be multiple
pathways of conformational folding which influence oxidative folding.

vii

TABLE OF CONTENTS
CHAPTER

PAGE

1 Introduction ......................................................................................................... 1
1.1 Structure and folding of protein .................................................................... 1
1.1.1 Protein structure ..................................................................................... 1
1.1.2 In vitro protein folding .......................................................................... 2
1.1.2.1 Process of in vitro protein production ............................................ 2
1.1.2.2 Importance of protein folding ......................................................... 6
1.1.3 Folding of disulfide containing proteins ............................................... 8
1.1.4 Folding with Protein Disulfide Isomerase (PDI) .................................. 8
1.1.4.1 General information ....................................................................... 8
1.1.4.2 Oxidative protein folding with PDI ............................................... 10
1.1.4.2.1 Oxidative in vivo protein folding with PDI .............................. 10
1.1.4.3 Oxidative in vitro protein folding with PDI .................................... 11
1.1.4.4 Folding with small molecules ....................................................... 12
1.2 Folding of bovine pancreatic trypsin inhibitor (BPTI) .................................. 16
1.2.1 Introduction of BPTI .............................................................................. 16
1.2.2 Traditional in vitro oxidative folding of BPTI ......................................... 20
1.2.3 Updated folding pathway of BPTI ......................................................... 24
1.3 Folding of BPTI with aromatic thiols and their corresponding disulfides .... 26
1.3.1 Introduction ........................................................................................... 26
1.3.2 Construction of the structure of small molecule aromatic thiols ........... 27
1.4 Molecular dynamics (MD) simulation study of BPTI ................................... 29
1.4.1 Importance of MD simulation ................................................................ 29
1.4.2 Protein folding and MD simulation ........................................................ 29
1.4.3 Molecular dynamics (MD) simulation of BPTI ...................................... 30
2 Objectives ......................................................................................................... 32
2.1 Synthesis of different aromatic thiols and their corresponding disulfides
for the study of folding of reduced BPTI .............................................................. 32
2.2 Folding of reduced BPTI faster using different aromatic thiols and their
corresponding disulfides ...................................................................................... 32
2.3 Molecular dynamics (MD) simulation study of BPTI intermediates to
understand the folding of BPTI at a molecular level ............................................ 32
3 Synthesis of aromatic thiols and corresponding disulfides ............................... 33
3.1 Abstract ...................................................................................................... 33
3.2 Introduction ................................................................................................. 34
3.3 Results and discussion ............................................................................... 37
3.3.1 Synthesis of quaternary ammonium salt thiol 1 .................................... 37
3.3.2 Synthesis of quaternary ammonium salt thiol 2 .................................... 37
3.3.3 Synthesis of quaternary ammonium salt thiol 3 .................................... 40
3.3.4 Synthesis of quaternary ammonium salt thiol 4 .................................... 40

viii

3.3.5 Synthesis of sulfonic acid thiol 9 .......................................................... 41
3.4 Experimental section .................................................................................. 42
3.4.1 Synthesis of 1-(4-(mercaptophenyl)-N,N,N-trimethylmethanaminium
bromide (1) .......................................................................................................... 42
3.4.1.1 Synthesis of S-p-tolyl benzothiophenol (13) ................................... 42
3.4.1.2 Synthesis of S-4-(bromomethyl)phenyl benzothiophenol (14) ....... 43
3.4.1.3 Synthesis of 1-(4-(benzoylthio)phenyl-N,N,Ntrimethylmethanaminium bromide (15) ................................................................ 43
3.4.1.4 Synthesis of 1-(4-(mercaptophenyl)-N,N,Ntrimethylmethanaminium bromide (1) .................................................................. 44
3.4.2 Synthesis of 2-S-(4-mercapto)benzyl)-N,N,N-trimethylethanaminium
bromide [extended QAS thiol] (2) ........................................................................ 44
3.4.2.1 Synthesis of 2-S-(4-(benzothio)benzyl)ethanol (16) ....................... 44
3.4.2.2 Synthesis of 2-S-(4-(benzoylthio)benzyl)-1-bromoethane (17) ...... 45
3.4.2.3 Synthesis of 2-S-(4-(benzoylthio)benzyl)-N,N,Ntrimethylethanaminium bromide (18) ................................................................... 45
3.4.2.4 Synthesis of 2-S-(4-mercapto)benzyl)-N,N,Ntrimethylethanaminium bromide (2) ..................................................................... 46
3.4.2.5 Synthesis of 1,1'-(4,4'-disulfanediylbis(1,4-phenylene)bis(2-SN,N,N-trimethylethanaminium) bromide [Disulfide of extended QAS thiol] (6) .... 46
3.4.3 Synthesis of hexyl QAS thiol ................................................................ 46
3.4.3.1 Synthesis of 1-(4-(benzoylthio)phenyl)-N,N-dimethyl-Nhexylmethanaminium bromide (20) .................................................................... 46
3.4.3.2 Synthesis of 1-(4-mercaptophenyl)-N,N-dimethyl-Nhexylmethanaminium bromide (3) ....................................................................... 47
3.4.4 Synthesis of octyl QAS thiol ................................................................. 47
3.4.4.1 Synthesis of 1-(4-(benzoylthio)phenyl)-N,N-dimethyl-Noctylmethanaminium bromide (22) ...................................................................... 47
3.4.4.2 Synthesis of 1-(4-mercaptophenyl)-N,N-dimethyl-Noctylmethanaminium bromide (4) ........................................................................ 48
3.4.5 Synthesis of 4-mercaptobenzene sulfonic acid (9) ............................... 49
3.4.5.1 Preparation of sodium-4,4'-dithiobis(benzenesulfonate) (26) ......... 49
3.4.5.2 Synthesis of 4-mercaptobenzene sulfonic acid (9) ......................... 50
3.5 Conclusion .................................................................................................. 50
4 Dramatic increase in the folding rate of Bovine Pancreatic Trypsin Inhibitor
(BPTI) with the buffer composed of positively charged aromatic thiol and its
corresponding disulfide ....................................................................................... 52
4.1 Abstract ...................................................................................................... 52
4.2 Introduction ................................................................................................. 53
4.3 Results ....................................................................................................... 57
4.3.1 Folding with negatively charged aromatic thiols and their
corresponding disulfides ...................................................................................... 59
4.3.2 Folding with positively charged aromatic thiol 1 and its
corresponding disulfide 5 .................................................................................... 61

ix

4.4 Discussion .................................................................................................. 71
4.5 Experimental section .................................................................................. 76
4.5.1 Materials ............................................................................................... 76
4.5.2 Preparation of reduced BPTI ................................................................ 77
4.5.3 Oxidative folding of reduced BPTI ........................................................ 78
4.6 Conclusion .................................................................................................. 79
5 Targeted Molecular Dynamics (TMD) simulation study of conformational
folding from [5-55] like conformation to native conformation of BPTI .................. 81
5.1 Abstract ...................................................................................................... 81
5.2 Introduction ................................................................................................. 82
5.3 Methods ...................................................................................................... 85
5.3.1 Molecular dynamics (MD) setup for equilibrium and TMD ................... 85
5.4 Results and discussion ............................................................................... 86
5.4.1 TMD using all atoms ............................................................................. 87
5.4.1.1 Change in structural configuration of BPTI during TMD ................. 87
5.4.1.2 Distance between CYS residues of the native disulfide bonds ...... 89
5.4.1.3 Root mean square deviation during TMD ....................................... 90
5.4.1.4 Analysis of intermediates with the change in radius of gyration ..... 91
5.4.1.5 Analysis of folding trajectories ....................................................... 93
5.4.2 TMD using Cα and sulfur of cysteines (SG) only .................................. 94
5.4.2.1 Change in structural conformation during simulation ..................... 94
5.4.2.2 Root mean square deviation analysis ............................................ 95
5.4.2.3 Distance analysis of native disulfide bonds .................................... 96
5.4.2.4 Analysis of intermediates with the change in radius of gyration ..... 98
5.4.2.5 Analysis of trajectories ................................................................... 99
5.5 Conclusion ................................................................................................ 101
6 Conclusion ...................................................................................................... 102
7 Future works ................................................................................................... 104
References ........................................................................................................ 105
VITA................................................................................................................... 116

x

LIST OF FIGURES
FIGURE

PAGE

1.1 Four levels of protein structure ........................................................................ 2
1.2 Thiol-disulfide interchange reaction during renaturation of protein ................. 5
1.3 Mechanism of aggregation of amyloid fibrils ................................................... 7
1.4 Structure of human PDI ................................................................................. 10
1.5 Open and closed CXXC motif of PDI ............................................................ 10
1.6 Proposed mechanism of thiol-disulfide exchange between Ero1p and a
thioredoxin-like domain of PDI ............................................................................ 11
1.7 Oxidative protein folding mechanism in vivo ................................................. 12
1.8 Some traditional small molecule thiols and disulfides ................................... 14
1.9 Generic structures of aromatic thiol and disulfide ......................................... 16
1.10 Structure of BPTI ......................................................................................... 18
1.11 Thermal denaturation of BPTI at pH 2.1 ...................................................... 18
1.12 The BPTI folding pathway proposed by Creighton ...................................... 22
1.13 The folding pathway of BPTI proposed by Kim ........................................... 23
1.14 Updated oxidation-rearrangement BPTI folding pathway ............................ 26
3.1 Quaternary ammonium salt (QAS) thiols 1-4 and their corresponding
disulfides 5-8 ....................................................................................................... 36
3.2 Sulfonic acid thiol 9 and its disulfide 10 ......................................................... 36
3.3 Side products of the first step in the preparation of compound 16 ................ 39
3.4 Tosylation of 16 ............................................................................................. 40
4.1 Mechanism of PDI ......................................................................................... 55
4.2 Different aromatic thiols and their corresponding disulfides .......................... 58

xi

4.3 Folding of reduced BPTI with 0.09 mM disulfide 10 and different
concentrations of thiol 9 ...................................................................................... 60
4.4 Total area of protein in different folding conditions with thiol 9 and
disulfide 10 .......................................................................................................... 61
4.5 Folding of reduced BPTI with 0.09 mM disulfide 5 and different
concentrations of thiol 1 ...................................................................................... 62
4.6 Folding of reduced BPTI with 0.25 mM disulfide 5 and different
concentrations of thiol 1 ...................................................................................... 63
4.7 Total area of protein in different folding conditions with thiol 1 and
disulfide 5……………………………………………………………………………….63
4.8 Oxidation of thiol 1 in different folding conditions with thiol 1 and
disulfide 5……………………………………………………………………………….64
4.9 Prominent intermediate during folding of reduced BPTI with 0.25 mM disulfide
5 and thiol 1 at 38 min ......................................................................................... 64
4.10 Prominent intermediate during folding of reduced BPTI with 0.25 mM
disulfide 5 and thiol 1 at 42 min ........................................................................... 65
4.11 Different quenching conditions .................................................................... 65
4.12 Folding of reduced BPTI with 0.25 mM disulfide 5 and different
concentrations of thiol 1 ...................................................................................... 66
4.13 Analysis of total protein area with different storage methods ...................... 67
4.14 Total protein area in new HPLC method ..................................................... 68
4.15 Folding of reduced BPTI with 0.25 mM disulfide 5 and different
concentrations of thiol 1 ...................................................................................... 68
4.16 Chromatogram showing native protein and intermediates with 0.25 mM
disulfide 5 and 10 mM thiol 1 ............................................................................... 69
4.17 Chromatogram showing native protein and intermediates with 0.25 mM
disulfide 5 and 1 mM thiol 1 ................................................................................. 69
4.18 Chromatogram showing native protein and intermediates with 0.25 mM
disulfide 5 and 2 mM thiol 1 ................................................................................. 70

xii

4.19 Chromatogram showing native protein and intermediates with 0.25 mM
disulfide 5 and 5 mM thiol 1 ................................................................................. 70
4.20 Folding of reduced BPTI with 10 mM thiol 1 and different concentrations
of disulfide 5 ........................................................................................................ 71
4.21 Comparison of folding of reduced BPTI with our optimal condition (10
mM thiol 1 and 0.25 mM disulfide 5) with optimal condition of traditional
buffer (5 mM GSH and 5 mM GSSG) .................................................................. 71
4.22 Effect of negatively and positively charged thiols on net charge of BPTI
............................................................................................................................. 74
5.1 Native structure of BPTI showing α-helices (in red), β-strands (in green),
disulfide bonds (in yellow), and loops and turns (in blue) .................................... 87
5.2 The folding secondary structure of BPTI with its three disulfide bonds ......... 88
5.3 Snapshots of conformations formed at different stages of conformational
changes during conformational folding of BPTI using TMD simulation. Sulfur
atoms of cysteines are shown in yellow balls ..................................................... 88
5.4 Evolution of secondary structure from TMD simulations of BPTI [(5-55) to
N]………………………………………………………………………………………...89
5.5 Distance between sulfur atoms in native disulfide bonds ............................. 90
5.6 Change in RMSD during TMD of BPTI ......................................................... 91
5.7 Folding trajectories demonstrating the BPTI folding pathway from [5-55]
conformation to folded native state ..................................................................... 93
5.8 Snapshots of different conformations formed during TMD simulation of
[5-55] like conformation of BPTI to native like BPTI ............................................ 94
5.9 Snapshots of conformations formed at different stages of conformational
changes during conformational folding of BPTI using TMD simulation ............... 95
5.10 Change in RMSD during TMD .................................................................... 96
5.11 Distance between sulfur atoms in native disulfide bonds ........................... 97
5.12 Formation of native and non-native disulfide bonds .................................... 98

xiii

5.13 Folding trajectories demonstrating the BPTI folding pathway from
[5-55] conformation to folded native state ......................................................... 100
5.14 Snapshots of different conformations formed during TMD simulation of
[5-55] like conformation of BPTI to native like BPTI .......................................... 101

xiv

LIST OF SCHEMES
SCHEME

PAGE

1.1 Nucleophilic substitution in thiol-disulfide interchange reaction .................... 28
1.2 Rearrangement of protein disulfide with aromatic thiolate ion ....................... 28
1.3 Formation of protein disulfide with aromatic disulfide .................................... 29
3.1 Synthesis of quaternary ammonium thiol 1 ................................................... 38
3.2 Synthesis of elongated quaternary ammonium thiol 2 .................................. 39
3.3 Synthesis of hexyl QAS thiol 3 ...................................................................... 40
3.4 Synthesis of octyl QAS thiol 4 ....................................................................... 41
3.5 Synthesis of sulfonic acid thiol 9 ................................................................... 41
4.1 Intra- and intermolecular formation of disulfide bonds .................................. 54
4.2 Reactions of aromatic thiol as a nucleophile and/or central thiol in a
redox buffer ......................................................................................................... 73

xv

LIST OF ABBREVIATIONS AND ACRONYMS
ATP

Adenosine triphosphate

BMC

(±) Trans-1,2-bis(mercaptoacetamido)cyclohexane

BME

Beta mercaptoethanol

BPTI

Bovine pancreatic trypsin inhibitor

CHARMM

Chemistry at Harvard Macromolecular Mechanics

CTD

C-terminal domain

Cu2+

Copper ion

Ca

Alpha carbon

DIPEA

Diisopropylethylamine

DMF

Dimethylfermamide

DTT

Dithiothreitol

DTTox

Oxidized dithiothreitol

DTTred

Reduced dithiothreitol

EDTA

Ethylenediaminetetraacetic acid

ER

Endoplasmic reticulum

Ero1p

Endoplasmic reticulum oxidoreductase protein 1

FAD

Flavin adenine dinucleotide

GSH

Glutathione

GSSG

Glutathione disulfide

GUI
Gdn-HCl

Graphical user interface
Guanidinium chloride

HCl

Hydrochloric acid

xvi

HPLC

High performance liquid chromatography

kDa

Kilodalton

KCl

Potassium chloride

MD

Molecular dynamics

NAMD

Nanoscale molecular dynamics

NMA

N-methylmercaptoacetamide

NMR

Nuclear magnetic resonance

PA

Phosphonic acid

PCDs

Protein conformational disorders

PDB

Protein data bank

PDI

Protein disulfide isomerase

QAS

Quaternary ammonium salt

Rg

Radius of gyration

RMSD

Root mean square deviation

RP

Reverse phase

SA

Sulfonic acid

SG

Sulfur of cysteine

SN2

Substitution nucleophilic bimolecular reaction

TFA
TMD

Trifloroacetic acid
Targeted molecular dynamics

UV-vis

Ultraviolet-visible

VMD

Visual molecular dynamics

xvii

CHAPTER 1
Introduction
1.1 Structure and folding of protein
1.1.1 Protein structure
Gerhardus Johannes Mulder, a Dutch chemist, first described and coined
the name ‘protein' in 1838 meaning ‘the first quality.1 Proteins are polymers of
amino acids and are composed of nitrogen, carbon, hydrogen, oxygen and sulfur.
In humans, protein consists of 15.1 percent of a person’s dry weight.2 Proteins
are enzymes, hormones, antibodies, and major components of tissues such as
hair and muscles. Proteins play a primary role in most biological processes such
as building, repairing and replacing tissues.
Protein structure is described in four levels - primary, secondary, tertiary,
and quaternary (Figure 1.1). The primary structure of a protein is the actual
sequence of amino acids in that protein which is set by DNA. The primary bonds
of any protein are the peptide bonds between amino acids. Biosynthesis of a
protein’s primary structure occurs on the ribosome with information provided by
messenger RNA in a process called translation.3 The secondary structure of a
protein is a local structural conformation, which is determined by H-bonds within
the backbone. There are mainly two types of secondary structure in proteins: the

a-helix and the b-sheet. The tertiary structure of a protein is the overall threedimensional structure of a single protein molecule which is described by distant
interactions between groups. These interactions include H-bonding, Vander
Waals interactions, hydrophobic packing, and disulfide bonding. The quaternary

1

homodimer) or different (as in a het- sequence of the protein can then be the secondary structure of a protein of the protein structure.
The use of NMR to determine the
erodimer). The quaternary structure analyzed by means of peptide map- is circular dichroism spectroscopy
refers to how these protein subunits ping and the use of Edman degrada- (CD). The different types of second- three-dimensional structure of a prointeract with each other and arrange tion or mass spectroscopy. This pro- ary structure, α-helix, ß-sheet and tein has some advantages over X-ray
themselves to form a larger aggregate cess is routine for peptides and small random coil, all have characteristic diffraction in that it can be carried
protein complex. The final shape of proteins, but becomes more complex circular dichroism spectra in the far- out in solution and thus the protein
the protein complex is once again for large multimeric proteins.
uv region of the spectrum (190-250 is free of the constraints of the crysstabilized by various interactions, inPeptide mapping generally entails nm). These spectra can be used to tal lattice. The two-dimensional NMR
techniques generally used are NOcluding hydrogen-bonding,
approximate the fraction
of the entreatment of the
with different
structure disulfideof a protein
is protein
formed
by interactions
between
individual
protein
bridges and salt bridges. The four protease enzymes in order to chop up tire protein made up of each type of ESY, which measures the distances
between atoms through space, and
levels of protein structure are shown the sequence into smaller peptides structure.
whichofmeasures
in Figure 2. subunits. These four
at specific
cleavage
Two com-structure
A more complete,
high-resolution
levels
of sites.
a protein
are crucial
to theCOESY,
stability
the distances
monly used enzymes are trypsin and analysis of the three-dimensional through bonds.
Protein Stability
chymotrypsin. Mass spectroscopy has structure of a protein is carried out
Protein Structure Stability Analysis
Due to thefolded
nature of native
the weak inbecome an invaluable
tool for the using X-ray crystallography or nuclear
conformation
of a protein.
Many different techniques can be
teractions controlling the three-diFigure 2
used to determine the stability of a
mensional structure, proteins are very
protein. For the analysis of unfolding
sensitive molecules. The term native
LEVELS OF PROTEIN STRUCTURE
of a protein, spectroscopic methods
state is used to describe the protein in
such as fluorescence, UV, infrared
its most stable natural conformation
Primary Structure
and CD can be used. Thermodynamic
in situ. This native state can be disHO O
methods such as differential scanrupted by a number of external stress
C
ning calorimetry (DSC) can be useful
factors including temperature, pH, rein determining the effect of temperamoval of water, presence of hydrophoH H
ture on protein stability. Comparative
bic surfaces, presence of metal ions
N
peptide-mapping (usually using LC/
and high shear. The loss of secondary,
MS) is an extremely valuable tool in
tertiary or quaternary structure due to
determining chemical changes in a
exposure to a stress factor is called
protein such as oxidation or deamidenaturation. Denaturation results in
dation. HPLC is also an invaluable
unfolding of the protein into a random
means of analyzing the purity of a proor misfolded shape.
H
tein. Other analytical methods such
A denatured protein can have quite
C C
Secondary Structure
N
as SDS-PAGE, iso-electric focusing
a different activity profile than the
O
O
O
C
H
and capillary electrophoresis can also
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H
H
H
C
N
C
N C C
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O
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O
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protein biopharmaceutical. The state
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C N C
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ditions.
O
sponses when administered.
The variety of methods for deterIn addition to these physical forms
mining protein stability again emphaof protein degradation, it is also imsizes the complexity of the nature of
portant to be aware of the possible
protein structure and the importance
pathways of protein chemical degTertiary Structure
Quaternary Structure
of maintaining that structure for a
radation. These include oxidation,
successful biopharmaceutical proddeamidation, peptide-bond hydrolyuct.
sis, disulfide-bond reshuffling and
cross-linking. The methods used in
References
the processing and the formulation of
proteins, including any lyophilization
1. Protein Structure, Stability and
step, must be carefully examined to
Folding, Methods in Molecular Biolprevent degradation and to increase
ogy, Vol. 168, Edited by Kenneth P.
the stability of the protein biopharMurphy
maceutical both in storage and during
2. Protein Stability and Folding,
drug delivery.
Theory and Practice, Methods in Molecular Biology, Vol. 40, Edited by
Particle Sciences
Bret A. Shirley
Phone: +1 610 861 4701

4
Particle
Sciences is a4).
leading
integrated provider of formulation
Figure 1.1. Four levelsFax:of+ protein
structure (From
reference
610 861 4702
3894 Courtney Street
Email: info@particlesciences.com
Bethlehem,
PA 18017-8920,
1.1.2
In vitro USA
proteinwww.particlesciences.com
folding

and analytic services and both standard and nanotechnology
approaches to drug development and delivery.

1.1.2.1 Process of in vitro protein production
The advancement in recombinant DNA technology has allowed the
production of therapeutic proteins5 in microbial hosts; Escherichia coli is the most

2

common organism used. In many cases, the protein of interest misfolds and
forms insoluble aggregates known as inclusion bodies.6 The major desirable
factor associated with the production of inclusion bodies either in the cytoplasm
or in the periplasm of E. coli is the rapid formation of the desired protein.7
Additional advantages associated with the overexpression include issues related
to toxicity of desired protein to the host cell are eliminated by the production of
that particular protein via inclusion bodies formation,8 the large quantity of
inclusion bodies expressed is highly enriched with a particular protein, and
inclusion bodies are protected from proteolytic degradation.8 But, there are still
some disadvantages of the expression of the protein as inclusion bodies such as;
the of inactivity and insolubility of the protein within the inclusion bodies, poising
a difficulty in solubility for further steps of protein production.6 Inclusion body
formation is particularly important in the case of disulfide containing proteins, as
the disulfide bond formation requires an oxidative environment which is not found
in the cytosol of bacteria.9 The result is the aggregation of protein. However, the
challenge remains with the regeneration of active and soluble proteins from these
misfolded aggregates.5,9 The recent advancement in the restoration process has
made it possible to produce large quantities of therapeutic proteins from highly
dense inclusion bodies which reach to 90% at optimal conditions.5
Formation of active protein from inclusion bodies involves several steps.
The first step is the isolation and purification of the inclusion bodies. Isolation is
done using one of two procedures. The most common method is cell lysis
followed by centrifugation of the resulting suspension at modest rotor speed.10
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The other method of isolation is the separation of inclusion bodies from soluble
proteins by filtration.8 The isolated inclusion bodies are contaminated mainly with
membrane associated proteins. The membrane associated proteins and other
contaminants are washed away with a mixture containing EDTA and a low
concentration of denaturant or detergent such as deoxycholate, octylglucoside,
or Triton X-100.8,11 The next step is the solubilization of the purified inclusion
bodies which is commonly accomplished by using strong denaturants such as
urea or guanidinium chloride (Gdn-HCl). During the solubilization of the inclusion
bodies the protein is either completely unfolded or partially unfolded as the
intramolecular and intermolecular interactions are disrupted. In the case of
disulfide-containing proteins, proteins within the inclusion bodies contain both
non-native inter- and intra-molecular disulfide bonds, which diminishes the
solubility. Therefore, the addition of thiol containing reagents such as bmercaptoethanol, dithiothreitol (DTT), dithioerythritol, cystamine, glutathione
(GSH), or cysteine along with the denaturants mentioned above at alkaline pH is
required.12 These reagents are necessary to break disulfide bonds via thioldisulfide interchange reactions forming reduced protein which is more soluble
than protein with mismatched or intermolecular disulfide bonds. The last step in
the in vitro protein production via the formation of inclusion bodies is the
renaturation of the solubilized inclusion proteins. The excess of denaturants and
thiol reagents are first removed using different methods such as dilution, dialysis,
gel-filtration chromatography, immobilization on a solid support, etc. followed by
the exposure of reduced protein to oxidizing conditions. The refolding process is
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highly dependent on pH, temperature, and ionic strength of the protein; therefore,
these factors must be carefully considered during the optimization of the
renaturation step.5
The renaturation of disulfide containing proteins must be performed in a
redox buffer containing an oxidizing agent and in the case of monothiols a
reducing agent.5,9 For example, glutathione (GSH), the reduced form, and
glutathione disulfide (GSSG), the oxidized form, mixed in the proper molar ratio
can be utilized to increase the rate and yield of the formation of an active protein
by facilitating thiol-disulfide interchange reactions. Other redox systems which
can be used are pairs like DTT/GSSG, cysteine/cystine, cysteamine/cystamine.8
A small amount of EDTA is added during the preparation of the redox buffer to
prevent the oxidation of the protein thiols and redox buffer by air in the presence
of metal ions such as Cu2+.
RSSR
S

RS

S

RS
S

RSSR

RSS

S

S

RS

RS

Figure 1.2. Thiol-disulfide interchange reaction during renaturation of protein
where RS- is the deprotonated reduced form and RSSR is the oxidized disulfide
form.
The renaturation process of disulfide containing proteins can be improved
by the addition of low molecular weight additives which prevent the aggregation
of wrongly folded species by suppressing intermolecular interactions.8 Different
denaturants such as urea, GdnHCl, and detergents such as CHAPS, Triton X100, SDS, CTAB can be added as small molecule additives.
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1.1.2.2 Importance of protein folding
The protein folding process can potentially start in several different places:
in the cell co-translationally during protein synthesis on the ribosomes, in the
cytoplasm after the protein has been synthesized and released from the
ribosome, or in a particular compartment of the cell such as the endoplasmic
reticulum (ER) or mitochondria after the protein has been translocated through a
membrane.13 The ER contains the specialized machinery used to fold intraorganellar, secretary, and transmembrane proteins.14 The highly crowded milieu
(300-400 gL-1 occupied mainly by proteins, polysaccharides, and lipids) of the
cell increases the possibility of protein aggregation.15,16 To overcome the
aggregation problem, molecular chaperones are present in the cell. These
chaperones prevent aggregation by not allowing the nascent protein molecules to
interact with other molecules in the crowded environment of the cell. The
chaperones guide protein folding either in the initial stage or later stages of the
process, increasing the efficiency of the folding process.13,17,18
In the case of incorrect folding, the aggregation of protein results in the
formation of highly ordered amyloid fibrils (Figure.1.3), which are very stable and
are responsible for neurodegenerative diseases.15 They have been grouped
under protein conformational disorders (PCDs). In some cases, the aggregated
proteins deposit in tissues, including heart and brain, resulting in diseases such
as Alzheimer's disease, Parkinson’s disease, spongiform encephalopathies, and
type II diabetes. The misfolded proteins, as a result of a change in conformation
lose their biological activity and acquire toxicity to the cell.
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Figure 1.3. Mechanism of aggregation of amyloid fibrils (From reference 13).13
The misfolded proteins associated with the protein misfolding diseases
have an extra stability. Therefore, during in vitro protein folding, it is very
important to fold proteins into their correct three-dimensional shape, so as to
obtain biological function, and not toxic activity.
The in vitro oxidative protein folding of disulfide containing proteins is done
in the presence of a redox buffer containing both oxidizing and reducing
equivalents. The progress of the folding process is studied by analyzing the
intermediates formed, which can be isolated after quenching the reaction mixture
after a certain amount of time.19 Oxidative protein folding method is applicable
solely for the folding of disulfide containing proteins. Oxidative protein folding
method has some advantages over the conformational protein folding process,
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which is used to fold all types of proteins. These benefits include the use of a
protein with clearly defined disulfide bonds, and the ease of trapping, isolation,
and characterization of folding intermediates, as well as evaluation of the kinetics
of the folding pathway, and control of kinetics by changing the redox reagents.19
1.1.3 Folding of disulfide containing proteins
Disulfide bond formation in secretary proteins is an essential process for
their stability and biological activity as it decreases the entropy of the reduced
form and thus increases the relative stability of the native form. However, in
comparison with other proteins, the process of folding disulfide containing
proteins is very slow and requires a redox environment.20 Oxidative protein
folding in vivo is an assisted process which takes place in the ER of the cell. The
ER contains protein disulfide isomerase (PDI), a protein involved in the
rearrangement of mismatched disulfide bonds and oxidation-reduction of
disulfide bonds. The ER has an oxidative environment compared to the cytosol
as a result of the presence of different redox enzymes and small molecule
oxidants, and also because of the secretion and uptake of thiols and disulfides,
respectively.21
1.1.4 Folding with Protein Disulfide Isomerase (PDI)
1.1.4.1 General information
The enzyme PDI belongs to the thiol-disulfide oxidoreductase family and
is located in the endoplasmic reticulum (ER) of the cell22 It was first isolated and
characterized by Anfinsen and co-workers.23 Protein disulfide isomerase (PDI) is
a 55 kDa, multifunctional protein found abundantly in the lumen of ER and
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primarily takes part in the formation of correct disulfide bonds via isomerization of
disulfide bonds.24 The structure of PDI contains two active thioredoxin domains
(a and a¢), two inactive thioredoxin domains (b and b¢) and an acidic C-terminal
tail resulting in a “U” shaped structure (Figure 1.4).24 The active domains (a and
a¢) each contain one catalytically active C-G-H-C motif located near the N
terminus in the a domain and near the C terminus in the a¢ domain. The two C-GH-C motifs face each other and are separated by 20 Å (distance between sulfur
of C61-C406).24,25 The cysteines in each active site can be either in the disulfide
form (oxidized PDI), because of an intramolecular bond formation, or in the dithiol
form (reduced PDI). In reduced PDI, one thiol in each active site is exposed to
the solvent and the other thiol is buried in the hydrophobic core. The solvent
exposed thiol is responsible for the reactivity of PDI (pKa = 6.7) with other
disulfide bonds. Oxidized PDI contains one disulfide bond in a cyclic 14membered ring form (Figure 1.5) and is unstable as compared to other disulfides
as a result of a lower redox potential (E'0 = -180 mV).26 Thus, thiol-disulfide
interchange reactions take place rapidly with oxidized and reduced PDI, making
PDI a model for designing small molecule thiols and disulfides.
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Figure 1.4 Structure of human PDI(PDB ID 4EKZ).22
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Figure 1.5 Open and closed CXXC motif of PDI.
1.1.4.2 Oxidative protein folding with PDI
1.1.4.2.1 Oxidative in vivo protein folding with PDI
Once the polypeptides are formed, these nascent structures containing
cysteines in the reduced thiol form are translocated to the ER with the help of
signal recognition particles as well as receptors.27 In the ER, the conditions are
much more oxidizing than in the cytosol ([GSH]/[GSSG] = 1:1 to 1:3 in ER, 100:1
in the cytosol), which is thermodynamically favorable for disulfide bond formation
in proteins and hence PDI is present mostly in the oxidized form.25,28,29 The
protein disulfide bond is formed due to the transfer of oxidizing equivalents from
Ero1p to PDI29 (Figure 1.6).
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Figure 1.6 Proposed mechanism of thiol-disulfide exchange between Ero1p and
a thioredoxin-like domain of PDI.29
The PDI itself acts as a chaperone thereby preventing proteins from
forming an aggregation. The reduced proteins form disulfide bonds with the help
of oxidized PDI as oxidized PDI act as an electron acceptor whereas mismatched
disulfide bonds within proteins are isomerized to native disulfide bonds with the
help of reduced PDI which acts as an electron donor. The isomerization of the
mismatched disulfide bond is started by the attack of the solvent-exposed thiolate
of PDI on disulfide bond of the substrate protein forming a mixed disulfide bond
between the protein and PDI (Figure 1.7). Then, the resulting thiol of the
substrate protein can attack another disulfide bond. A series of thiol-disulfide
reaction results in the formation of native disulfide bonds in the substrate
protein.30 The regaining of oxidized PDI will take place via the series of reactions
involving Ero1p and its cofactor Flavin Adenine Dinucleotide (FAD), and
molecular oxygen.
1.1.4.3 Oxidative in vitro protein folding with PDI
In vitro oxidative protein folding can be aided by the addition of PDI, which
also catalyzes in vivo protein folding in the ER of the cell via a series of thioldisulfide interchange reactions.31 For in vitro protein folding, PDI is mixed with a
redox buffer which improves protein folding by preventing the unfolded proteins
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from aggregating and increasing the rate of thiol-disulfide interchange
reaction.32,33 The use of PDI for in vitro protein folding is not efficient as a
consequence of its high cost of production, low catalytic activity, and
instability.32,34 However, in vivo in the ER, the concentration of PDI is high.
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Figure 1.7 Oxidative protein folding mechanism in vivo.35
1.1.4.4 Folding with small molecules
Oxidative in vitro protein folding of disulfide containing proteins is
conventionally done using a redox buffer prepared with a small molecule aliphatic
thiol and/or the corresponding disulfide.36,37 As these small molecules contain
either a thiol or a disulfide group in their structure; they can react with protein
thiols/disulfides in multiple steps until the native protein is formed. The native
protein is a kinetically stable protein structure having only native type disulfide
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bonds. Some of the traditional small molecule thiols and disulfides include
glutathione (GSH) and glutathione disulfide (GSSG), reduced dithiothreitol
(DTTred)

and

oxidized

dithiothreitol

(DTTox),

reduced

and

oxidized

b-

mercaptoethanol (BME), reduced and oxidized cysteine, reduced and oxidized
(±) trans-1,2-bis(mercaptoacetamido)cyclohexane (BMC), reduced and oxidized
cystamine38,39 (Figure 1.8). In general, the reduced and oxidized forms of the
small molecules are mixed to prepare the redox buffer.40,41 Out of the abovementioned redox systems, only two of them have been studied extensively for
their effect on protein folding: DTTox/DTTred and GSSG/GSH.42
The GSSG/GSH system is found in vivo, where folding of disulfide
containing proteins take place. Therefore, the GSSG/GSH redox system is the
one most commonly used for oxidative protein folding experiments especially for
proteins like BPTI, RNase A, and lysozyme.43 The optimal conditions to fold
these proteins are: 0.2 mM GSSG and 1 mM GSG for RNase A,44 2 mM GSSG
and 7 mM GSH for lysozyme,45,46 and 2 mM GSSG and 2 mM GSH or 5 mM
GSSG and 5 mM GSH for BPTI.42
Dithiothreitol (DTT) has a reduction potential (E°') of -0.327 V; therefore, it
is a weak oxidizing agent.47 Even in the case of high molar concentration of
oxidized DTT, the refolding rate of RNase A is very slow as compared to GSSG
at much lower concentrations.36 The advantage of using DTT is that DTT
catalyzes protein folding without the formation of stable mixed disulfide
intermediates; hence, the characterization of the folding pathway becomes
easier.36
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For the large-scale production of proteins, less expensive oxidative folding
agents are desired. Therefore, cysteine, cystamine, and β-mercaptoethanol are
applicable as these compounds are cheaper than glutathione. Cystamine has a
lower thiol pKa than glutathione and has a net positive charge at pH 7; hence, it
is more advantageous for basic proteins like BPTI.43
An aliphatic dithiol (±)-trans-1,2-bis(2-mercaptoacetamido)cyclohexane
(BMC) has two thiol groups in close proximity and upon oxidation can form a
comparatively less stable cyclic disulfide. The yield of protein folding can be
increased significantly with BMC31 as demonstrated by Raines et al. during the
folding of RNase A. When 1 mM BMC was added to a folding mixture containing
1 mM GSH and 0.5 mM GSSG, the yield of protein was two-fold as compare to
folding yield with N-methylmercaptoacetamide (NMA),36 which is the monothiol
analog of BMC. The additional thiol group present in BMC helps increase the
folding yield of proteins in comparison to NMA. Therefore, it is desirable to add
an even low concentration of BMC to the folding mixture whether in vivo or in
vitro to increase the yield.
Aromatic thiols and their corresponding disulfides (Figure 1.9) can be
utilized more efficiently as a redox buffer to fold disulfide containing proteins
because of their enhanced reactivity at physiological pH and lower thiol pKa
values (4-7) as compared to their aliphatic counterparts. In addition, the thiol pKa
is similar to that of the solvent exposed thiol of protein disulfide isomerase
(PDI).48 The enhanced reactivity is primarily dependent upon the better leaving
group ability of the thiolate ion due to the higher stability of the thiolate anion as a
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result of the lower pKa values of the corresponding thiols. Hence, small molecule
aromatic thiols and disulfides enhance the thiol disulfide interchange reactions
occurring during folding experiments.
R

SH

R

Aromatic thiol

S S

R

Aromatic disulfide

Figure 1.9 Generic structures of aromatic thiol and disulfide.
The folding rates of reduced RNase A and lysozyme were increased
multiple folds with aromatic thiols in comparison to GSH. For example, folding of
reduced RNase A was increased by the factor of 23 at pH 6, by the factor of 12
at pH 7 and by a factor of 8 at pH 7.7 relative to GSH.38,49 Similarly, folding
experiments on reduced lysozyme showed that the folding rate was increased by
the factor of 11 and yield by 40% with aromatic thiols and the corresponding
disulfides relative to GSH and GSSG at pH 7.50 Aromatic thiols with thiol pKa
values 1-2 units lower than the pH of the folding mixture were found to the best in
terms of the reactivity. Therefore, we sought to synthesize aromatic thiols with
expected thiol pKa values 5.5-6.5 as we are running folding experiments at pH
7.3 to mimic physiological conditions. I expect to dramatically increase in the
folding rate of reduced protein with aromatic thiols and corresponding disulfides.
1.2 Folding of bovine pancreatic trypsin inhibitor (BPTI)
1.2.1 Introduction of BPTI
Bovine pancreatic trypsin inhibitor (BPTI) with 58 amino acid residues is
one of the smallest globular proteins known, and its sole function is to bind to and
inhibit serine proteases such as trypsin. The sequence of amino acids in BPTI is
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RPDFC LEPPY TGPCK ARIIR YFYNA KAGLC QTFVY GGCRA KRNNF KSAED
CMRTC GGA.51 With 10 positively charged lysine (K) and arginine (R) residues
and 4 negatively charged aspartate (D) and glutamates (E) residues, the protein
is strongly basic at neutral pH and is sometimes called basic pancreatic trypsin
inhibitor. However, as the usual source for BPTI is bovine pancreas, the protein
is primarily referred to as bovine pancreatic trypsin inhibitor. Residue 15 of BPTI,
which is lysine, has a long basic side chain on an exposed loop of the structure.
Lysine is responsible for binding the specificity pocket in the active site of trypsin
hence inhibiting its enzymatic activity. Trypsin inhibitors usually have conserved
cysteine residues that participate in forming disulfide bonds. BPTI has α-helical
and β-sheet regions as well as three disulfide bonds between Cys5-Cys55,
Cys14-Cys38, and Cys30-Cys51, which stabilize the protein's tertiary structure52
(Figure 1.10). Three disulfide bonds in 58 residues make BPTI one of the most
stable proteins known. BPTI was first isolated as a trypsin inhibitor from bovine
pancreas in 1936.53 The crystal structure was solved by Robert Huber in 1970.54
The first NMR structure was determined by Kurt Wuthrich at ETH in Zurich in
1980.55 BPTI was the first protein to be studied computationally using molecular
dynamics.56 BPTI is also the most-studies disulfide containing protein in terms of
folding pathway.
BPTI is quite inert to denaturants like urea at below 100˚C but denatures
in very acidic solutions; the midpoint for reversible denaturation is 81˚C at pH 2.1
(Figure 1.11).57 If only one of the disulfide bonds, that formed between cysteine
residues 14 and 38, is reduced and then carboxymethylated, the midpoint
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decreases to 59˚C, hence denaturation becomes more facile than without
carboxymethylation (Figure 1.11).
14
38

30 51
55
5

Figure 1.10. Structure of BPTI.58

Figure 1.11. Thermal denaturation of BPTI at pH 2.1 (From reference 59).59
When all three disulfide bonds of BPTI are reduced at room temperature,
the protein unfolds. Upon oxidation under suitable conditions, native BPTI with its
unique set of three disulfide bonds is formed. If BPTI were reduced to yield six
cysteine residues and randomly re-oxidized, it would produce about 7% native
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protein (1/15), as there are 15 possible combinations of BPTI with three disulfide
bonds (Table 1.1). The first SH group to pick a partner will have five choices, the
second SH group three partners, and the last SH group one partner. Therefore
there are 5×3×1, or 15, possible combinations.60,61
Table 1.1: 15 possible combinations of six cysteine residues in BPTI
Combinations

1st Disulfide bond

2nd Disulfide bond

3rd Disulfide bond

1

5-14

30-38

51-55

2

5-14

30-51

38-55

3

5-14

30-55

38-51

4

5-30

14-38

51-55

5

5-30

14-51

38-55

6

5-30

14-55

38-51

7

5-38

14-30

51-55

8

5-38

14-51

30-55

9

5-38

14-55

30-51

10

5-51

14-30

38-55

11

5-51

14-38

30-55

12

5-51

14-55

30-38

13

5-55

14-30

38-51

14*

5-55

14-38

30-51

15

5-55

14-51

30-38

*native BPTI
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Previous studies of BPTI and other proteins containing disulfide bonds
indicated that correct pairing of cysteines is achieved if appropriate conditions
are selected and sufficient time is allowed.60 The meaning of the finding is that
the folding path of the protein places the SH groups in position for correct pairing.
The corollary of this statement is that the S-S bridges are not essential for proper
refolding. But, the formation of S-S bond contributes to the extra stability of the
protein structure once the protein is folded. A protein containing S-S bridges has
a smaller number of conformations available in the unfolded form than does a
comparable protein without the bridges. Consequently, it shows a lower entropy
gain on unfolding and is therefore stabilized.60,62
1.2.2 Traditional in vitro oxidative folding of BPTI
The in vitro oxidative folding of fully reduced BPTI was traditionally carried
out in the presence of DTTox and GSSG. The folding pathways were determined
from the study of trapped intermediates. The folding study of BPTI was originally
examined by Creighton who refolded reduced BPTI (R) at pH 8.7 in the presence
of DTTox followed by the trapping of folding intermediates chemically using
iodoacetamide to alkylate free thiols.63,64 These intermediates were separated via
ion-exchange chromatography followed by analysis using two-dimensional paper
electrophoresis. The study identified two main 1SS (contains one disulfide bond)
intermediates, five main 2SS (contains two disulfide bonds), intermediates and
only one 3SS (contains three disulfide bonds) protein structures (Figure 1.12).
Out of the two 1SS intermediates only one is native like (contains [30-51]
disulfide bond), out of the five 2SS intermediates, three are native like, N' [30-51;
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14-38], N* [5-55; 14-38], and NSH [30-51; 5-55], and the one 3SS containing
structure is the native protein N [30-51; 5-55; and 14-38]. The disulfide bond
found in the most abundant one disulfide intermediate, [30-51], is present in all
two-disulfide intermediates identified except in N*. Two of the 2SS intermediates
containing non-native disulfide bonds, [30-51; 5-14] and [30-51; 5-38], were
highly populated in Creighton’s study.
From Creighton's work, it was revealed that the two well populated 2SS
non-native intermediates have an important role in guiding the folding pathway to
the native structure. These two 2SS intermediates which contain (30-51) as one
of the two disulfide bonds have similar kinetic behavior and did not form
substantially during the folding process but rearranged to another disulfide
intermediate NSH [30-51; 5-55] which further rearranges rapidly to native BPTI N
[30-51; 5-55; and 14-38]. The native like 2SS intermediate N* [5-55; 14-38] was
found to be very stable kinetically and only very slowly rearranged to NSH [30-51;
5-55], so the intermediate was called non-productive. The folding pathway of
BPTI goes through two well populated non-native 2SS intermediates, [30-51; 514] and [30-51; 5-38] and the route is favored kinetically.
Later, the oxidative folding study of reduced BPTI was studied extensively
by Kim and his team using a modified separation technique. The folding reaction
was quenched at certain time points using an acid to stop further thiol-disulfide
interchange reactions. Acid quenching has the advantage over the conventional
method in that the process is reversible and the trapped and purified
intermediates can be used for further folding experiments so that the folding
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process can be studied in detail. The intermediates formed were separated and
analyzed by reverse phase HPLC (RP-HPLC).65 In his study, Kim found that only
six different species accumulated during folding and that all contained native
disulfide bonds: [30-51], [5-55], N' [30-51; 14-38], N* [5-55; 14-38], NSH [30-51; 555], and N [30-51; 5-55; 14-38] (Figure 1.13).
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Figure 1.12 The BPTI folding pathway proposed by Creighton.64 R is reduced
form and N is native form of BPTI. Numbers with dash sign inside bracket
represent the disulfide bonds present in respective structures.
The fully reduced BPTI (R) was oxidized to all possible single disulfide
intermediates which rapidly rearrange to either [30-51] or [5-55]. These single
disulfide intermediates are converted quickly to two disulfide intermediates N',
and N* as the thiols of Cys14 and Cys38 are solvent exposed and form a
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disulfide bond easily. As N* has buried Cys30 and Cys51 in its interior, the thiols
of Cys30 and Cys51 are inaccessible to oxidizing agents and hence N* cannot
undergo either oxidation or rearrangement on the experimental time scale;
therefore, the route that forms N* is regarded as nonproductive.66 On the other
hand, the pathway via N', which also has two buried thiols, Cys5 and Cys55, is
productive because this intermediate can rearrange to the more stable
intermediates N* and NSH. The transition to NSH does not depend upon the
concentration of oxidizing agents, which means that the transition is via an
intramolecular thiol-disulfide interchange reaction.63,66 Conversion of N' to NSH is
the rate determining step in protein folding.65,67 In the final step leading to the
formation of native BPTI, oxidation of Cys14 and Cys38 takes place forming the
(14-38) bond.
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Figure 1.13 The folding pathway of BPTI proposed by Kim.64,65 R is reduced form
and N is the native form of BPTI. The numbers inside the box separated by a
dash are disulfide bonds. N', N*, and NSH are native like 2SS intermediates. Very
fast means the process can be finished within milliseconds and very slow means
it could take months.65
Subsequent studies by Kim et al. of the oxidative folding of reduced BPTI
using GSSG concluded that the slow rate of direct oxidation of N' to N is because
of the native-like structure of N' which slows down the intermolecular reaction
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with GSSG to form a mixed disulfide as well as the subsequent intramolecular
reaction leading to N.68 The formation of N by direct oxidation requires high
concentration of GSSG which also leads to the formation of a dead-end doubly
mixed disulfide intermediate; therefore, folding via direct oxidation of N' does not
form N in considerable amounts. During oxidative folding, two reactions were
seen in competition. One is the formation of N from the singly mixed disulfide
N'(SG), and the other is the formation of N'(SG)2 from N'(SG). The formation of
singly mixed disulfide N'(SG) is from the oxidation of one of the free thiols of
Cys5 or Cys55. At modest GSSG concentration, the formation of singly mixed
disulfide N'(SG) is slower than the rearrangement of N' to NSH. As the rate of
formation of N from NSH is 150 times faster than the rate of formation of singly
mixed disulfide N'(SG) from N', the formation of N takes place via intramolecular
rearrangement. At high GSSG concentrations (> 500 µM), formation of doubly
mixed disulfide N'(SG)2 from singly mixed disulfide N'(SG) is 30 times faster than
the formation of N'(SG) from N'; therefore, the process does not allow the
formation of a considerable amount of N. The conclusion is that complete
unfolding of native like intermediates N' and N* as seen in BPTI folding, is
common to all disulfide containing proteins.68
1.2.3 Updated folding pathway of BPTI
Recent investigation by Yingsong and Lees on the folding of reduced BPTI
via a growth type pathway and updated the BPTI folding pathway (Figure 1.14).69
A growth type pathway is a protein folding model where the rate determining
step(s) in the folding reaction is the nucleation of native-like conformation
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followed by the smooth formation of conformation with native disulfide bonds,70
The folding condition optimized previously by Kibria and Lees with GSH and
GSSG were 5 mM GSH and 5 mM GSSG to fold reduced BPTI to 93% native
protein in 48 h.42 Conformational kinetic trap N* and oxidative kinetic trap N'(SG)2
which is also called doubly mixed disulfide, were observed in the reaction and
were balanced under optimal conditions. The formation of protein doubly mixed
disulfide with 5 mM GSH and 5 mM GSSG suggested that growth type pathways
were needed to efficiently fold reduced BPTI. Wang et al. determined the rate
constants for many of the steps that occur during the folding of reduced BPTI. On
the basis of these rate constants, the best folding conditions for BPTI were
predicted assuming only two changes to the redox buffer of GSH/GSSG were
made during the folding process. The conversion took place via the formation of
N*(SG). The folding of reduced BPTI was initiated with 2 mM GSSG and 5 mM
GSH to convert all reduced BPTI to disulfide intermediates, N' and N* were
formed as primary intermediates occupying 50% of the total concentration. Then,
30 mM GSH was added after 15 min, total GSH concentration was 35 mM, to
reduce the rest of the intermediates like N', N'(SG), N'(SG)2. The reduced
proteins were converted to the thermodynamically more stable intermediate N*
as these intermediates react with GSSG. After 1 h, 50 mM GSSG was added and
the reaction continued for 12 h to produce 93% N. N* was previously regarded as
a dead-end kinetic trap. The finding was helpful to increase the yield of native
protein because folding via the productive route: N' to NSH to N or N' to N'(SG) to
N was limited by the formation of doubly mixed disulfide N'(SG)2.
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Figure 1.14 Updated oxidation-rearrangement BPTI folding pathway.65,68,69
1.3 Folding of BPTI with aromatic thiols and their corresponding disulfides
1.3.1 Introduction
The enhanced reactivity of aromatic thiols and their corresponding
disulfides towards thiol-disulfide interchange reactions and the feasibility of their
synthesis in lab are very important aspects for their application in protein folding.
The pKa values of aromatic thiols can be altered by changing the side chain
attached to the aromatic ring. Therefore, the synthesis of small molecule
aromatic thiols with nearly the same thiol pKa as the free thiol of PDI, and that
are soluble in water in both the thiol and disulfide forms, should enhance the
reactivity of these small molecules aromatic thiols at pH 7 relative to the
traditionally used aliphatic thiols such as glutathione. The enhancement of the
folding rate of proteins with aromatic thiols in comparison to glutathione was
demonstrated previously in our group. As described, aromatic thiols speed up the
folding rate of lysozyme by 11 and 7 times and increased its yield by 40% and
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25% at pH 7and 8 respectively.50 Additionally, the rate of folding for RNase A
was also found to be enhanced up to 23 times at pH 6, up to 12 times at pH 7,
and up to 8 times at pH 7.7 with aromatic thiols as compared to glutathione.37
Therefore, replacing glutathione with aromatic thiols in the redox system can
expedite the rate of folding of disulfide containing proteins at neutral pH and a
further increase in relative rate can be achieved by decreasing the pH of the
redox buffer.46
1.3.2 Construction of the structure of small molecule aromatic thiols
The structure of aromatic thiols should have the following characteristics:
these small molecule thiols should have charged side chain so that the thiols are
soluble in buffer, the thiol group should have a pKa value very close to neutral
pH, and the molecules should be easily separated from protein after the folding
assay is completed so that it will not hamper the analysis. The charged groups
are either negatively charged like sulfonic acid and phosphoric acid, or positively
charged like quaternary ammonium salt. These groups are installed in the
structure during their synthesis. The thiol pKa values can be calculated from the
σp- a value of the substituent. The Hammett plot has a slope of -1.6, ρ = 1.6±0.1.48
The formation of disulfide bonds takes place via a nucleophilic substitution
mechanism. A thiolate ion (R1S¯) attacks the disulfide bond (R2SSR3) and
substitutes (R3S¯), as a result, a new disulfide bond (R1SSR2) is formed as
shown in scheme 1.1. In the reaction, R1S¯ acts as a nucleophile, R3S¯ serves as
a leaving group, and R2S¯ serves as the center of attack.34,39 The rate of the thiol-

27

disulfide interchange reaction is dependent upon several factors including the
stability of the leaving group and the nucleophilicity of the attacking group.
Scheme 1.1 Nucleophilic substitution in thiol-disulfide interchange reaction

R1 S

+

+
R3 S
S S
R1 R2
Leaving group
New disulfide bond

S S
R2 R3
Thiolate Disulfide bond

Therefore, the basis for the design of small molecule aromatic thiols for
protein folding is to enhance the rate of thiol-disulfide interchange reactions
which take place between the small molecules and proteins during oxidative in
vitro protein folding. The rate of rearrangement of protein disulfide bonds found in
the folding intermediates can be a slow process, as I have observed in the
folding of reduced BPTI; hence, aromatic thiolate ions will expedite the process
(Scheme 1.2). Native disulfide bonds formation with aromatic thiols involve
reduction of non-native disulfides to thiols and rearrangement of non-native
disulfide bonds to native disulfide bonds. Aromatic disulfides also help in
increasing the rate of formation of protein disulfide bonds (Scheme 1.3) because
aromatic thiolates are stable leaving groups. Our aim to fold BPTI faster is highly
dependent upon the rate of formation and rearrangement of protein disulfides
with the aid of aromatic thiols and their corresponding disulfides.
Scheme 1.2 Rearrangement of protein disulfide with aromatic thiolate ion
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Scheme 1.3 Formation of protein disulfide with aromatic disulfide
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1.4 Molecular dynamics (MD) simulation study of BPTI
1.4.1 Importance of MD simulation
Molecular dynamics (MD) simulation is a computational method which is
regarded as a primary method for the theoretical study of the biomolecules at
their atomistic levels to insight into their structure, function, and dynamics. Atoms
and molecules are interacted for the fixed time providing a view of the details of
the interactions of the system. The method of MD simulation has its application in
wide range of science including physics, chemistry, biochemistry, biophysics, and
structural biology. Growing advancement of methodology and computer power is
helping to study the larger systems and variety of conformational changes
utilizing the longer time of simulation to find the details of a process going on
inside the body which is not possible from experiments.71 The three-dimensional
structure of proteins is predicted via the MD simulation of folding of a random coil
of that particular proteins.
1.4.2 Protein folding and MD simulation
The knowledge of a folding process of a newly synthesized protein helps
to understand the basic principle of life at its atomistic levels.72 The field of
medicine can take the advantages of the molecular dynamics (MD) simulation of
protein folding process as the study can facilitate the development of the
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treatment methods of diseases associated with protein misfolding.73 The study of
protein folding helps the field of nanotechnology because the investigation can
reveal the principle behind the folding.73 Both the experimental74 and
computational75 methods have been advancing to elucidate the process of
conformational changes of proteins. MD simulation has been improvised and
coupled with the ultrafast, inexpensive computers to study the unfolding and
folding of proteins in their atomistic levels.76
1.4.3 Molecular dynamics (MD) simulation of BPTI
Bovine pancreatic trypsin inhibitor (BPTI) is the first protein which was
tested with molecular dynamics (MD) simulations in vacuo.56 After eleven years,
MD simulation of BPTI done in water at the same time was reported stating that
the simulation was run for higher time scales and improved the results giving
better RMSD value and reducing the number of incorrect hydrogen atoms as
opposed to the simulation run in vacuo.77 The presence of water molecules in
simulation provides more realistic motion of protein and structure will attain very
close to the crystal structure.77 Later on, simulation on BPTI has been performed
in different laboratories.78–82
Bovine pancreatic trypsin inhibitor (BPTI), as it contains three disulfide
bonds, has an extra stability in its native form. During simulation, if the disulfide
bonds are included as constraints, can reduce the conformational space. Saito
and coworkers were the first to study the protein folding/unfolding of disulfide
containing proteins assuming that folding starts with the formation of secondary
structure (α-helices and β-sheets) followed by the attaining the tertiary
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structure.83,84 The simulation on finding the role of disulfide bonds in protein
folding revealed that folding of disulfide containing proteins undergoes with
different pathways to the native form via the formation of native-like intermediates
only, but the process is mediated by the formation of non-native intermediates.85
The results were in agreement with both the conflicting experimental results by
Creighton,86 and Weissman and Kim.65 Another study on disulfide bonds and
protein folding by Scheraga and coworkers87 concluded that the conformational
folding and the disulfide bond formation are extremely cooperative process as
well as the development and breaking of disulfide bonds in the disulfide
containing proteins takes place when certain conditions such as closeness of
cysteine residues, orientation, and easiness of thiols to oxidizing agents are
fulfilled. Lately, MD simulation works on BPTI revealed that the initially formed
specifically collapsed structure of protein similar to native form guides the
formation of disulfide bonds.88 Herein, the importance of conformations of
intermediates during folding in the formation of disulfide bonds is described,
taking BPTI as a model protein, and using targeted molecular dynamics (TMD)89
simulation. Targeted MD is a great computational tool to study the conformational
changes of starting structure to an assigned target structure with the application
of time-dependent geometrical constraint, usually run at ordinary temperature.90
As the process of conformational folding and disulfide bond formation are
coupled to each other, the TMD simulation study on BPTI would give an
opportunity to understand the mechanism of conformational changes and
disulfide bond formation visually.
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CHAPTER 2
Objectives
The aims of my dissertation research are to synthesize aromatic thiols and
their corresponding disulfides, and to investigate the folding of reduced BPTI
using these compounds.
2.1 Synthesis of different aromatic thiols and their corresponding
disulfides for the study of folding of reduced BPTI
Four different QAS thiols and their corresponding disulfides as well as one
sulfonic acid thiol and its disulfide will be prepared with the expectation that they
will improve the efficiency and folding rate of reduced BPTI.
2.2 Folding of reduced BPTI faster using different aromatic thiols and their
corresponding disulfides
Three different aromatic thiols (PA, SA, and QAS) are used to fold
reduced BPTI at physiological pH selecting different concentrations of the thiols
and the corresponding disulfides to prepare the redox buffer. The best thiol in our
folding study as well as the best condition will be determined and the results
compared with the traditional folding buffer GSSG/GSH.
2.3 Molecular dynamics (MD) simulation study of BPTI intermediates to
understand the folding of BPTI at a molecular level
The molecular mechanism of the conformational changes at an atomistic
level will be modeled. The software NAMD will be used for the simulation study
and the software VMD will be used for visualization of the simulation.
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CHAPTER 3
Synthesis of aromatic thiols and corresponding disulfides
3.1 Abstract
The use of redox buffers containing an aromatic thiol and its
corresponding disulfide were found to increase the in vitro folding rate of disulfide
containing proteins compared to buffers composed of an aliphatic thiol and its
corresponding disulfide. The increased folding rate with aromatic thiols at
physiological pH, 7.3, is attributed to their lower thiol pKa values (4-7), greater
nucleophilicity at neutral pH, and enhanced leaving group ability. Oxidative
protein folding in the endoplasmic reticulum (ER) of a cell is aided by protein
disulfide isomerase (PDI). The enzyme PDI contains two active sites each with a
CXXC motif where one of the cysteine is buried and the other is solvent exposed
and has a thiol pKa of 6.7. I synthesized five different aromatic thiols and their
corresponding disulfides with expected pKa values close to the pKa of the
solvent exposed thiol of PDI: Four positively charged quaternary ammonium salt
thiols and their corresponding disulfides, and one negatively charged sulfonic
acid thiol and its corresponding disulfide. The folding of reduced bovine
pancreatic trypsin inhibitor (BPTI) was performed with a redox buffer composed
of one positively charged thiol and its disulfide, and one negatively charged thiol
and its disulfide. The results showed that the positively charged thiol folded
reduced BPTI faster as compared to the traditional redox buffer composed of
aliphatic thiol, glutathione (GSH), and its disulfide glutathione disulfide (GSSG).
Although the negatively charged aromatic thiol and its disulfide were found to fold
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reduced BPTI rapidly, the protein also precipitated. It is expected that the other
positively charged thiols and their corresponding disulfides will also fold reduced
BPTI more efficiently.
3.2 Introduction
The number, importance, and use of protein-based drugs are expected to
increase dramatically over the next five years.91 The total number of protein
based drugs approved worldwide is around 650.92 Out of these 650, about 400 of
them are produced using recombinant DNA technology. An additional 1300 drugs
are being developed.92 Almost all of these drugs contain disulfide bonds and a
third of them are produced in E. coli. Overexpression of proteins in E. coli is
efficient as large amounts of protein are rapidly produced. However,
overexpressed disulfide-containing proteins tend to misfold and aggregate as
inclusion bodies inside E. coli. The aggregated protein is then resolubilized and
folded oxidatively in vitro to obtain active protein.8 Oxidative protein folding in
vitro as well as in vivo involves the conformational folding of proteins combined
with the oxidation of protein thiols to disulfides, and the reduction and
rearrangement of protein disulfides. During rearrangement non-native disulfide
bonds are rearranged to native disulfide bonds.42
Oxidative protein folding has traditionally been performed with a redox
buffer of glutathione (GSH) and glutathione disulfide (GSSG), as these aliphatic
small molecules are found in the endoplasmic reticulum (ER) of eukaryotes
where in vivo oxidative protein folding takes place.93 The slow step(s) in oxidative
protein folding in vitro involve(s) thiol-disulfide interchange reactions. The thiol-
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disulfide interchange reactions during protein folding occur between protein
thiol/disulfide and small molecule thiol/disulfide, where thiolate ion, deprotected
thiol, attacks a disulfide. As the reaction goes through the nucleophilic
substitution mechanism, the rate of the reaction depends on the concentration of
the thiolate ion in the solution, which ultimately depends on the thiol pKa and the
pH of a solution.38,94 In eukaryotic cells, thiol-disulfide interchange reactions are
catalyzed by protein disulfide isomerase (PDI).31 One of the properties of PDI
that is believed to be important for catalysis is a nucleophilic low pKa thiol in the
active site. The PDI is effective but is expensive for in vitro oxidative protein
folding since it needs to be added in almost stoichiometric amounts.32,44
To improve in vitro protein folding, I sought to prepare small molecules
with nucleophilic low pKa thiols similar to PDI. Aromatic thiols have thiol pKa
values (pKa = 4-7) comparable to PDI and lower than those of aliphatic thiols,
such as GSH (pKa = 8.7).48,95 In addition, aromatic thiols are more nucleophilic
than aliphatic thiols with similar pKa values.96 Gough et al. demonstrated that a
redox buffer composed of aromatic thiols and disulfides increased the folding rate
of ribonuclease A 10 times in comparison to a redox buffer composed of GSH
and GSSG.49 These redox buffers composed of small molecule disulfides and
corresponding thiols, in variable concentrations, oxidize protein thiols to
disulfides as well as rearrange mismatched non-native disulfide bonds within
protein to native disulfide bonds.49
Herein, four different quaternary ammonium salt (QAS) thiols 1-4 and their
corresponding disulfides 5-8 (Figure 3.1), and the sulfonic acid (SA) thiol 9 and
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its disulfide 10 (Figure 3.2) were synthesized. Compounds 1, 5, 9, and 10 were
synthesized using previously reported methods50,97–99 and utilized for the folding
of BPTI. The redox buffer, composed of QAS thiol 1 and its disulfide 5, folded
reduced BPTI to about 90% completion within one hour without any indication of
protein precipitation. The redox buffer, composed of SA thiol 9 and its disulfide
10, folded reduced BPTI faster, but was found to be less suitable to be used as a
redox buffer since it resulted in protein precipitation. Compounds 2-4 and 6-8
were synthesized for the first time.
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Figure 3.1. Quaternary ammonium salt (QAS) thiols 1-4 and their corresponding
disulfides 5-8.
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Figure 3.2. Sulfonic acid thiol 9 and its disulfide 10.
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3.3 Results and discussion
Four different quaternary ammonium thiols (1-4) and their corresponding
disulfides (5-8), and one sulfonic acid thiol (9) and its disulfide (10) were
synthesized. Disulfides were synthesized by dissolving the corresponding thiols
in water and stirring in the presence of air until the disulfides were formed. The
completion of disulfide formation was confirmed using Ellman’s reagent.
Quaternary ammonium salt thiols with increased number of carbons in the side
chain were selected, as thiol 1 had shown significant improvement in protein
folding rates and yields.34,46 Increasing the hydrophobic side chain may result in
thiols more likely to enter the hydrophobic core of proteins.
3.3.1 Synthesis of quaternary ammonium salt thiol 1
The QAS thiol 1 was synthesized as shown in scheme 3.1. To protect the
SH group p-toluene thiol (11) and benzoyl chloride (12) were reacted in the
presence of trimethylamine to form compound 13. The protected compound 13
was then subjected to a radical bromination reaction with N-bromosuccinamide in
the presence of light to provide bromide 14. Compound 14 reacted with
trimethylamine to form QAS salt 15. The benzoyl protecting group was removed
from 15 by refluxing 15 with 8% HBr.
3.3.2 Synthesis of quaternary ammonium salt thiol 2
The QAS thiol 2 was prepared following scheme 3.2. Benzyl bromide 14
was reacted with b-mercaptoethanol in the presence of diisopropylethylamine
(DIPEA) to form alcohol 16. Compound 16 was then reacted with carbon
tetrachloride and triphenylphosphine to obtain bromide 17. Compound 17 was
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reacted with trimethylamine and formed QAS salt 18. The benzoyl protecting
group was removed from 18 by refluxing 18 with 8% HBr.
Scheme 3.1. Synthesis of quaternary ammonium thiol 1
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There were lots of challenges during the synthesis of 2. The first step was
the formation of an alcohol. Initially, it was challenging to find the correct base
that would initiate the reaction. Bases tried were potassium carbonate, potassium
hydroxide, sodium carbonate, cesium carbonate, silver carbonate, sodium
hydroxide, and DIPEA. Only potassium carbonate and DIPEA gave positive
results, however DIPEA was selected as it gave the highest yield and was easy
to dissolve. As the reaction should go through a SN2 mechanism, the polar
aprotic solvent DMF was selected. There was also a regioselective issue. The
thiolate from b-mercaptoethanol could attack either the benzylic carbon or the
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carbonyl carbon forming two different products. The best ratio obtained was 1:1.
Two different side products along with 42% of product were observed in the
1

HNMR spectra of the crude mixture. The proposed the following side products

(Figure 3.3) based on the NMR.
Scheme 3.2. Synthesis of elongated quaternary ammonium thiol 2
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Figure 3.3. Side products of the first step in the preparation of compound 16.
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The second step of formation of bromide 17 was attempted via the
formation of the tosylate. The product was the chloride rather than the expected
tosylate. The chlorinated compound did not react with trimethylamine so the
reaction was proceeded with the Appel reaction.
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Figure 3.4. Tosylation of 16.
3.3.3 Synthesis of quaternary ammonium salt thiol 3
Benzyl bromide 14 was reacted with N,N-dimethylhexylamine (19) to form
QAS salt 20. Compound 20 was refluxed for 35 h with 8% HBr to deprotect the
benzoyl group and form QAS thiol 3, Scheme 3.3.
Scheme 3.3. Synthesis of hexyl QAS thiol 3
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3.3.4 Synthesis of quaternary ammonium salt thiol 4
The formation of QAS thiol 4 is shown in scheme 3.4. Benzyl bromide 14
was reacted with N,N-dimethyloctylamine (21) to form QAS salt 22. Compound
22 on reflux with 48% HBr diluted with water for 35 h formed QAS thiol 4.
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Scheme 3.4. Synthesis of octyl QAS thiol 4
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3.3.5 Synthesis of sulfonic acid thiol 9
Preparation of sulfonic acid thiol 9 is shown in scheme 3.5. The reaction
was started by treating p-aminobenzenesulfonic acid (23) with diluted sodium
carbonate. The resulting sodium salt of p-aminobenzenesulfonic acid (24) was
treated with nitrous acid at low temperature forming diazonium salt (25).
Compound 25 was then reacted with disodium disulfide which resulted in
sodium-4,4¢-dithiobis(benzenesulfonate) (26). Compound 26 was run through an
H+ ion exchange column to form the disulfide of sulfonic acid thiol (10).
Compound 10 on treatment with triphenylphosphine in the presence of water
provided sulfonic acid thiol 9.
Scheme 3.5. Synthesis of sulfonic acid thiol 9
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The following intermediates were not isolated but were formed during the
synthetic pathway. Intermediate 10 was formed in between 26 and 9.
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3.4 Experimental section
3.4.1 Synthesis of 1-(4-(mercaptophenyl)-N,N,N-trimethylmethanaminium
bromide (1)
3.4.1.1 Synthesis of S-p-tolyl benzothiophenol (13)97
In the 500-mL round bottom flask, 11.5 mL of benzoyl chloride (13.91 g,
102.6 mmol), 2.39 g of p-toluene thiol (99.7 mmol), and 100 mL of ether were
mixed. The mixture was stirred and cooled in an ice-water bath. Then 18 mL of
triethylamine (13.07 g, 128.2 mmol) was added to an equal volume of ether (18
mL) and the resulting solution was added dropwise to the above mixture via a
dropping funnel over 30 min. The reaction mixture was subsequently left in the
ice-water bath for 1.5 h and then allowed to warm to room temperature. The
mixture was filtered and the solid washed with ether. The ether fractions were
combined and dried with MgSO4. After rotary evaporation of the solvent, 19.00 g
(83%) of the benzoyl derivative was obtained. 1H NMR (CDCl3, 400 MHz) δ 8.03
(dd, J = 8.4, 1.2 Hz, 2H), 7.62 (tt, J = 7.6, 1.2 Hz, 1H), 7.50 – 7.46 (m, 2H), 7.42
– 7.39 (m, 2H), 7.27 (d J = 8.0 Hz, 2H), 2.41 (s, 3H).
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3.4.1.2 Synthesis of S-4-(bromomethyl)phenyl benzothiophenol (14)
S-p-tolylbenzothiophenol

(13)

(10.16

g,

44.5

mmol)

and

N-

bromosuccinimide (7.97 g, 44.7 mmol) were mixed with deoxygenated benzene
(63.5 mL). The reaction mixture was irradiated with a 250W GE heat lamp, which
provided sufficient light energy to start reflux. After 30 min at reflux, the mixture
was cooled to 0°C, filtered and concentrated under reduced pressure. The
residue was partitioned between 300 mL of CH2Cl2 and 150 mL of water. The
aqueous layer was washed with 125 mL of CH2Cl2. The combined organic layers
were dried with MgSO4, filtered and concentrated. The solid was then
recrystallized from hexanes to obtain 8.36 g (61%) of product. The product also
contained 5% of S-4-(dibromomethyl)phenyl benzothiophenol. 1H NMR (CDCl3,
400 MHz) δ 8.01 (dd, J = 8.4, 1.2 Hz, 2H), 7.66 – 7.60 (t, 1H), 7.54 – 7.46 (m,
6H), 4.52 (s, 2H)
3.4.1.3

Synthesis

of

1-(4-(benzoylthio)phenyl)-N,N,N-

trimethylmethanaminium bromide (15)97
Benzyl bromide (14) (25.0 g, 81.4 mmol) was added in a round-bottomed
flask and cooled to 0°C. Trimethylamine (38.30 ml of a 33% solution in ethanol,
213.8 mmol) was then quickly added to the round-bottomed flask and the
resulting mixture was stirred for 10 min. The mixture was then concentrated
under reduced pressure, and the residue was recrystallized from EtOAc/EtOH
(95:5) to provide 17.1 g of quaternary ammonium salt (15), 57% yield. 1H NMR
(CDCl3, 400 MHz) δ 7.97 (d, J = 7.6 Hz, 2H), 7.81 (d, J = 8.0 Hz, 2H), 7.64 – 7.57
(m, 3H), 7.48 (t, J = 8.0 Hz, 2H), 5.19 (s, 2H), 3.41 (s, 9H).
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3.4.1.4 Synthesis of 1-(4-(mercaptophenyl)-N,N,N-trimethylmethanaminium
bromide (1)50,97
Quaternary ammonium salt (15) (1.86 g, 5.08 mmol) was dissolved in 6
mL of HBr (48% w/v in water) and 30 mL of water. The mixture was then refluxed
for 5 h. After cooling to 0°C, the mixture was filtered. The aqueous fraction was
lyophilized several times by redissolving the residue in 10 mL of water each time.
The quaternary ammonium salt thiol (1) was obtained quantitatively. 1H NMR
(CD3OD, 400 MHz) δ 7.43 (s, 4H), 4.50 (s, 2H), 3.10 (s, 9H).
3.4.2 Synthesis of 2-S-(4-mercapto)benzyl)-N,N,N-trimethylethanaminium
bromide [extended QAS thiol] (2)
3.4.2.1 Synthesis of 2-S-(4-(benzoylthio)benzyl)ethanol (16)
Benzyl bromide (14) (0.77 g, 2.5 mmol), N,N-diisopropylethylamine (0.32
g, 2.5 mmol), 2-mercaptoethanol (0.198 g, 2.5 mmol), and 10 mL of DMF were
mixed in round-bottomed flask and stirred for 15 min. Next, 1 N HCl (100 mL)
was added and the mixture was extracted with ethyl acetate (3 x 20 mL). The
organic layers were combined, dried with MgSO4 and concentrated in vacuo. The
residue was purified twice via silica gel chromatography using CH2Cl2: EtOAc
(10:1) and then hexane: EtOAc: CH2Cl2 (3:1:1) as the eluent to provide alcohol
(16) as a white solid, yield 0.282 g, 36%. 1H NMR (CDCl3, 400 MHz) δ 8.02 (dd, J
= 8.0, 0.8 Hz, 2H), 7.61 (t, J = 7.6 Hz, 1H), 7.51 – 7.46 (m, 4H), 7.42 (d, J = 8.0
Hz, 2H), 3.77 (s, 2H), 3.70 (t, J = 6.0 Hz, 2H), 2.66 (t, J = 6.0 Hz, 2H), 2.05 (brs,
1H);

13

C NMR (CDCl3, 100 MHz) δ 190.3, 139.9, 136.7, 135.4, 133.8, 129.9,

128.9, 127.6, 126.2, 60.4, 35.5, 34.4.
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3.4.2.2 Synthesis of 2-S-(4-(benzoylthio)benzyl)-1-bromoethane (17)100
A mixture of an alcohol (16) (0.304 g, 1.0 mmol) and CBr4 (0.365 g, 1.1
mmol) in CH2Cl2 (2 mL) was prepared in a 25-mL flask and cooled to 0°C.
Triphenyl phosphine (0.289 g, 1.1 mmol) was added via a powder funnel in
portions with vigorous stirring. Then, the mixture was stirred for 15 h at room
temperature. The mixture was then concentrated in vacuo and the residue
purified via silica gel chromagraphy with a mobile phase of hexane: EtOAc (3:1)
to provide 0.28 g of bromide (17) as a white solid, yield 76%.

1

H NMR

(CD3COCD3, 400 MHz) δ 8.03 (dd, J = 8.4, 1.2 Hz, 2H), 7.73 (t, J = 7.6 Hz, 1H),
7.60 (t, J = 8.0 Hz, 2H), 7.54 - 7.49 (m, 4H), 3.95 (s, 2H), 3.57 (t, J = 8.0 Hz, 2H),
2.92 (t, J = 8.0 Hz, 2H);

13

C NMR (CD3COCD3, 100 MHz), δ 189.8, 141.4, 137.5,

136.1, 134.9, 130.7, 130.0, 128.1, 126.8, 35.8, 34.1, 31.6.
3.4.2.3

Synthesis

of

2-S-(4-(benzoylthio)benzyl)-N,N,N-

trimethylethanaminium bromide (18)
Bromide 17 (0.28 g, 0.76 mmol) and 33% trimethyl amine in ethanol (0.41
mL, 2.29 mmol) were mixed in a 25-mL flask. After 2 d at room temperature, the
mixture was concentrated in vacuo and the residue was recrystallized from
EtOAc: EtOH (95:1) to provide 0.246 g of crystals of elongated QAS salt (18),
yield 75%. 1H NMR (CDCl3, 400 MHz) δ 7.98 (dd, J = 8.0, 0.8 Hz, 2H), 7.64 –
7.59 (m, 3H), 7.51- 7.45 (m, 4H), 3.97 (s, 2H), 3.53 – 3.48 (m, 2H), 3.34 (s, 9H),
2.89 – 2.85 (m, 2H);

13

C NMR (CDCl3, 100 MHz) δ 189.9, 138.7, 135.2, 134.8,

133.0, 129.4, 127.9, 126.5, 125.5, 64.6, 52.4, 34.9, 22.8.
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3.4.2.4 Synthesis of 2-S-(4-mercapto)benzyl)-N,N,N-trimethylethanaminium
bromide (2)
The quaternary ammonium salt (18) (1.08 g, 2.54 mmol) was dissolved in
3 mL of 48% HBr and 15 mL of water. The mixture was refluxed for 4 h and then
cooled to 0°C and filtered. The filtrate was then extraction with EtOAc (2 C 30
mL). The aqueous fraction was lyophilized several times by redissolving the
residue in 10 mL of water each time. The pure extended QAS thiol (2) was
obtained quantitatively. 1H NMR (D2O, 400 MHz) δ 7.34 (dd, J = 15.2, 8.0 Hz,
4H), 3.78 (s, 2H), 3.32-3.28 (m, 2H), 3.01 (s, 9H), 2.80-2.76 (m, 2H);

13

C NMR

(D2O, 100 MHz) δ 130.0, 129.9, 129.2, 128.5, 65.2. 52.8, 34.7, 22.7.
3.4.2.5 Synthesis of 1,1¢-(4,4¢-disulfanediylbis(1,4-phenylene)bis(2-S-N,N,Ntrimethylethanaminium) bromide [Disulfide of extended QAS thiol] (6)
The elongated QAS thiol (2) (0.0053 g, 0.016 mmol) was dissolved in 40
mL of water and stirred rapidly in the presence of air. After a week, the solution
was lyophilized to obtain the disulfide of elongated QAS thiol (6) quantitatively.
1

H NMR (D2O, 400 MHz) δ 7.57 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 3.80

(s, 2H), 3.26-3.22 (m, 2H), 2.94 (s, 9H), 2.79-2.75 (m, 2H);

13

C NMR (D2O, 100

MHz) δ 137.4, 135.5, 13.0, 126.3, 65.2. 52.7, 34.9, 23.2.
3.4.3 Synthesis of hexyl QAS thiol
3.4.3.1

Synthesis

of

1-(4-(benzoylthio)phenyl)-N,N-dimethyl-N-

hexylmethanaminium bromide (20)
Benzyl bromide 14 (2.72 g, 8.87 mmol) and N,N-dimethylhexylamine (19)
(1.54 mL, 8.84 mmol) were dissolved in 9 mL of ethanol and stirred for 6 h at

46

room temperature. The solvent was removed under reduced pressure and the
residue was washed with EtOAc (2 C 20 mL) to provide 2.75 g (71%) of product.
1

H NMR (CDCl3, 400 MHz) δ 8.01 (dd, J = 8.4, 1.2 Hz, 2H), 7.79 (d, J = 8.0 Hz,

2H), 7.66-7.60 (m, 3H), 7.50 (t, J = 8.0 Hz, 2H), 5.20 (s, 2H), 3.57-3.53 (m, 2H),
3.31 (s, 6H), 1.82 (brs, 2H), 1.34-1.28 (m, 6H), 0.89 (t, J = 7.2 Hz, 3H);

13

CNMR

(CDCl3, 100 MHz) δ 189.2, 136.2, 135.5, 134.0, 133.9, 131.2, 128.8, 128.4,
127.5, 66.7, 64.1, 49.7, 31.3, 25.9, 22.9, 22.4, 13.8.
3.4.3.2

Synthesis

of

1-(4-mercaptophenyl)-N,N-dimethyl-N-

hexylmethanaminium bromide (3)
The quaternary ammonium salt 20 (2.75 g, 6.3 mmol) was mixed with 6
mL of 48% HBr and 30 mL of water. The mixture was then refluxed for 35 h. The
contents were cooled to room temperature. The mixture was then extracted with
EtOAc (2 C 30 mL). The aqueous layer was then lyophilized. The resulting
residue was then repeatedly dissolved in water (10 mL) and lyophilized to
provide 2.03 g of QAS thiol 3 as a white solid, 97% yield. 1H NMR (CD3OD, 400
MHz) δ 7.42 (s, 4H), 4.49 (s, 2H), 3.33-3.29 (m, 2H), 3.01 (s, 6H), 1.87 (brs, 2H),
1.39-1.37 (m, 6H), 0.96-0.92 (m, 3H);

13

C NMR (CD3OD, 100 MHz) δ 138.2,

134.6, 129.9, 125.3, 68.4, 65.8, 50.3, 32.4, 27.1, 23.6, 23.5, 14.3.
3.4.4 Synthesis of octyl QAS thiol
3.4.4.1

Synthesis

of

1-(4-(benzoylthio)phenyl)-N,N-dimethyl-N-

octylmethanaminium bromide (22)
Benzyl bromide 14 (2.73 g, 8.88 mmol) and N,N-dimethyloctylamine (21)
(1.83 mL, 8.88 mmol) were dissolved in 9 mL of ethanol and stirred for 17 h at
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room temperature. The solvent was removed in vacuo. The residue was washed
with EtOAc (2 C 10 mL) to remove unreacted starting materials and provide 3.91
g (95%) of product. 1H NMR (CDCl3, 400 MHz) δ 7.99 (d, J = 7.6 Hz, 2H), 7.79
(d, J = 8.4 Hz, 2H), 7.65-7.57 (m, 3H), 7.49 (t, J = 8.0 Hz, 2H), 5.23 (s, 2H), 3.573.53 (m, 2H), 3.31 (s, 6H), 1.81 (brs, 2H), 1.35-1.24 (m, 10H), 0.87 (t, J = 6.8 Hz,
3H);

13

C NMR (CDCl3, 100 MHz) δ 189.1, 136.2, 135.5, 134.0, 133.9, 131.2,

128.8, 128.4, 127.5, 66.7, 64.1, 49.7, 31.6, 29.2, 29.0, 26.3, 22.9, 22.5, 14.0.
3.4.4.2

Synthesis

of

1-(4-mercaptophenyl)-N,N-dimethyl-N-

octylmethanaminium bromide (4)
The quaternary ammonium salt 22 (3.24 g, 6.97 mmol) was mixed with 7.2
mL of 48% HBr and 37.5 mL of water. The mixture was then refluxed for 35 h.
The contents were cooled to room temperature. The mixture was then
transferred to a seperatory funnel and extracted successively with EtOAc (3 C 40
mL). The EtOAc layers were then back extracted with 20 mL of H2O. The
combined aqueous layers were then lyophilized. Lyophilization was repeated
several times by dissolving the residue in 10 mL of water each time. The QAS
thiol (4) was obtained as a white solid producing 1.86 g, 74% yield. 1H NMR
(CD3OD, 400 MHz) δ 7.42 (s, 4H), 4.49 (s, 2H), 3.33-3.28 (m, 2H), 3.01 (s, 6H),
1.87 (brs, 2H), 1.40-1.32 (m, 10H), 0.93-0.89 (m, 3H);

13

C NMR (CD3OD, 100

MHz) δ 138.2, 134.6, 129.9, 125.3, 68.4, 65.8, 50.3, 32.9, 30.22, 30.21, 27.4,
23.7, 23.6, 14.4.
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3.4.5 Synthesis of 4-mercaptobenzene sulfonic acid (9)
3.4.5.1 Preparation of sodium-4,4'-dithiobis(benzenesulfonate) (26)99
p-Aminobenzenesulfonic acid (23) (47.5 g, 0.250 mol) and anhydrous
Na3CO3 (13.25 g, 0.130 mol) were dissolved in water (500 mL) by warming. The
solution was then cooled to 15°C. A solution of sodium nitrite (5 M) was prepared
by adding NaNO2 (18.5 g, 0.250 mol) in water (50 mL) and added to the solution
above. The mixture was then slowly added to a mixture of conc HCl (52.5 mL,
0.640 mol) and 300 g of crushed ice. A suspension of diazo compound 25 was
formed and then stirred for 15 min in an ice bath.
Sodium sulfide nonahydrate (65.2 g, 0.270 mol) and powdered sulfur (8.50
g, 0.270 mol) were dissolved in water (75 mL) by heating on a hot plate at 100°C.
Then a 10% NaOH solution (10.0 g NaOH in 100 mL H2O) was added and the
mixture was cooled to 0°C in an ice bath. Sodium disulfide was formed. The
diazo solution was added to the disulfide solution over a period of 30 min, along
with 50 g of ice to maintain the temperature below 5°C. After the addition was
completed, the vessel was removed from the ice bath and allowed to come to
room temperature. Once the evolution of nitrogen gas ceased, which took 2 h,
the reaction mixture was acidified to pH 2 with conc HCl. The precipitated sulfur
was removed by filtration and the filtrate was heated to remove hydrogen sulfide.
The heating was continued until the volume reached ca. 500 mL. The solution
was then cooled to room temperature and neutralized with 10% NaOH. The
volume was concentrated to 400 mL. The precipitate was filtered off and the
filtrate

was

kept

overnight

to
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provide

crystallized

sodium-4,4¢-

dithiobis(benzenesulfonate) (26). The crystallized product was separated by
filtration and recrystallized from 80% ethanol (650 mL) to provide 21.73 g of 26,
yield 42%. 1H NMR (D2O, 400 MHz) d 7.73 (d, J = 8.0 Hz, 4H), 7.64 (d, J = 8.4
Hz, 4H)
3.4.5.2 Synthesis of 4-mercaptobenzene sulfonic acid (9)99
Sodium-4,4¢-dithiobis(benzenesulfonate) (26) (4.22 g, 10 mmol) was
dissolved in water and subjected to ion-exchange column chromatography (20
mL of Dowex 50WC2-200 mesh, H-form) with water as eluent. The eluted acidic
fractions (150 mL) were evaporated to 35 mL and freeze dried to provide sulfonic
acid disulfide (10). The residue was dissolved in methanol (100 mL), and then
triphenylphosphine (6.1 g, 23.3 mmol) and 2 mL of water were added. The
mixture was stirred overnight at room temperature. The solution was then
evaporated under reduced pressure. The residue was dissolved in CH2Cl2 (60
mL) and extracted twice with water (100 mL then 50 mL). The aqueous layers
were combined and washed with CH2Cl2 (4 C 50 mL). The aqueous layer was
then freeze dried and the residue was recrystallized from benzene to give 1.56 g
of 4-mercaptobenzenesulfonic acid (9) as pale yellow crystals, yield 83%. 1H
NMR (D2O, 400 MHz) d 7.62 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H)
3.5 Conclusion
We have developed and implemented efficient methods to successfully
synthesize thiols 2-4 and their corresponding disulfides 6-8. The difficult step was
the reaction of b-mercaptoethanol with benzyl bromide 14. During the preparation
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of thiol 2, three products were formed which needed to be separated carefully
using silica gel column chromatography. In addition, the thiols needed to be kept
in the cold to prevent air oxidation, as this can occur easily if the thiols are
dissolved in water and left at room temperature. The successful preparation of
these thiols and disulfides will provide new opportunities for folding disulfide
containing proteins.
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CHAPTER 4
Dramatic increase in the folding rate of Bovine Pancreatic Trypsin Inhibitor
(BPTI) with the buffer composed of positively charged aromatic thiol and
its corresponding disulfide.
4.1 Abstract
Many of the most important pharmaceuticals on the market today are
proteins. A significant fraction of these proteins are produced in E. coli and need
to be oxidatively folded in vitro to obtain active protein, as they contain disulfide
bonds. The drawbacks of traditional oxidative protein folding in vitro are that it is
slow and low yielding, due to protein precipitation. In vitro oxidative protein
folding traditionally involves the use of a small molecule aliphatic thiol and
disulfide, such as glutathione (GSH) and glutathione disulfide (GSSG), as a
redox buffer to produce the active form of the protein. To improve oxidative
protein folding, small molecule thiols and disulfides were proposed that mimic the
nucleophilic low pKa thiol of protein disulfide isomerase (PDI) to fold proteins.
PDI catalyzes the folding of disulfide containing proteins in the endoplasmic
reticulum (ER) of eukaryotic cells. I demonstrated that aromatic thiols with
positively charged groups improved the folding rate of a reduced protein relative
to GSH/GSSG. The folding of BPTI was followed by reverse phase HPLC of
samples obtained by quenching folding reactions at specific times with formic
acid. More than 90% of native protein was obtained in an hour instead of the two
days taken with GSH and GSSG.
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4.2 Introduction
Disulfide bonds play a vital role in stabilizing the biologically active form of
numerous extracellular proteins and almost all pharmaceutically relevant
proteins. Many of these proteins can be produced efficiently in bacteria; however,
the proteins often aggregate as inactive inclusion bodies inside the cells. The
advantage of expression of a protein in inclusion bodies is that they can be
produced in large amounts, are easy to separate and are protected from
proteolytic degradation.8 Formation of inclusion bodies may also be the best
method of protein production if the protein of interest is toxic to the bacteria or
host cell. To produce active protein, the protein within the inclusion bodies is resolubilized and then oxidized in vitro. The disadvantage of the formation of
inclusion bodies is the need to refold the aggregated protein in vitro. Oxidative in
vitro protein folding involves conformational folding combined with oxidation of
protein thiols to native disulfide bonds. Formation of native disulfide bonds
involves reduction of protein disulfides to thiols and rearrangement of non-native
disulfide bonds to native disulfide bonds (Scheme 4.1).31 The reaction is highly
important at it is also responsible during the enzymatic formation and breaking of
disulfide binds in proteins.101
Bovine pancreatic trypsin inhibitor (BPTI) with 58 amino acid residues is
one of the smallest globular proteins known, and its sole function is to bind to and
inhibit serine proteases such as trypsin. For example, BPTI can inhibit trypsin-like
West Nile virus (WNV) NS2B-NS3 protease.102 Trypsin inhibitors usually have
conserved cysteine residues that participate in forming disulfide bonds (Figure
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1.10). Bovine pancreatic trypsin inhibitor (BPTI) has α-helical and β-sheet regions
as well as three disulfide bonds between Cys5 - Cys55, Cys14 - Cys38 and
Cys30 - Cys51, which stabilize the protein’s tertiary structure.52 Three disulfide
bonds in 58 residues make BPTI one of the most stable proteins known. When
all three disulfide bonds of BPTI are reduced at room temperature, the protein
unfolds. Upon oxidation under suitable conditions, native BPTI with its unique set
of three disulfide bonds is formed.
Scheme 4.1. Intra- and intermolecular formation of disulfide bonds31
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The folding pathway for BPTI is shown in the sketch (Figure 1.14), which
is based on previous studies of BPTI folding using GSH/ GSSG. N' and N* are
two disulfide-containing stable intermediates. N'(SG) and N*(SG) are singly
mixed disulfide-containing intermediates formed when N' and N* react with
glutathione disulfide, respectively. The intermediate N'(SG)2 is a doubly mixed
disulfide formed when the free thiol of N'(SG) reacts with GSSG. NSH is a
rearrangement product of N' and N* which undergoes oxidation to native protein.
In vitro protein folding can be aided by the addition of protein disulfide
isomerase (PDI), which is found in the endoplasmic reticulum (ER) and catalyzes
in vivo protein folding via a series of thiol-disulfide interchange reactions.31 The
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use of PDI for in vitro protein folding is not efficient due its high cost of
production, low catalytic activity and instability.34 However, in vivo in the ER, the
concentration of PDI is high. The design of small molecule thiols and disulfides
that improve protein folding is based on PDI. PDI is composed of two active sites
each consists of a CXXC motif required for its oxidoreductse activity where C is a
cysteine residue and X is any other amino acid.31,49,103 In each active site, one
cysteine thiol is exposed to solvent and other is buried in the hydrophobic core of
PDI. The solvent exposed thiol in PDI can attack a substrate disulfide bond
resulting in the formation of a mixed disulfide bond. The mixed disulfide bond can
be attacked by another thiol to form a new disulfide bond with the release of PDI
(Figure 4.1). The solvent exposed thiol has a low pKa value (6.7) and at neutral
pH is very reactive with disulfides as compared to small molecule aliphatic
thiols.48 Therefore, the synthesis of small molecule thiols with thiol pKa values
similar to that of the solvent exposed thiol in PDI is likely to increase the rate of in
vitro folding of disulfide-containing proteins.
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Figure 4.1. Mechanism of PDI.
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A redox buffer is composed of a small molecule disulfide and its
corresponding thiol in variable concentrations. During protein folding, the small
molecule disulfide oxidizes protein thiols to protein disulfides and the small
molecule thiol rearranges non-native protein disulfide bonds to native disulfide
bonds.49 Both processes are completed via thiol-disulfide interchange reactions
between the protein and the small molecules. There are several different factors
that

make

aromatic

disulfides/thiols

better

redox

buffer

than

aliphatic

disulfides/thiols. Different types of aromatic thiols with corresponding disulfides
are utilized to prepare a redox buffer. The thiol pKa values of aromatic thiols
range from 4-7 which is close to pKa value of the solvent exposed thiol of PDI.
Aromatic thiols with either electron releasing or electron withdrawing substituents
at the para position are utilized. In addition, aromatic thiols show enhanced
nucleophilicity at neutral pH and are better leaving group than aliphatic thiols. If
the para substituent is charged, then the aromatic thiol should have improved
water solubility.
Historically, aliphatic thiols/disulfides such as GSH, GSSG and oxidized
dithiothreitol (DTTox) were used for the oxidative folding of proteins. In vivo, GSH
and GSSG reduce protein disulfides and oxidize cysteine thiols to disulfides
respectively.93 Aliphatic thiols such as GSH, DDTred, β-mercaptoethanol, (±)
trans-1, and 2-bis(mercaptoacetamido)cyclohexane (BMC) have thiol pKa values
higher than 7.104 In comparison, aromatic thiols have a range of pKa values from
4 to 7 and are more reactive towards disulfides than aliphatic thiols with
comparable pKa values. Therefore, the thiol pKa value and enhanced reactivity
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of aromatic thiols mimic the properties of PDI.49,95 Therefore, selective synthesis
of small molecule aromatic thiols with nearly the same thiol pKa as that of the
free thiol of PDI, which are soluble in water in both the thiol and disulfide forms,
should enhance the reactivity of these small molecule aromatic thiols at pH 7
relative to the traditionally used aliphatic thiol such as glutathione.
Herein, I describe the dramatic increase in folding rate of reduced BPTI
with a redox buffer composed of an aromatic thiol and its corresponding disulfide
relative to the traditional folding buffer GSH/GSSG. Out of three aromatic thiols
investigated, quaternary ammonium salt thiol and its corresponding disulfide was
the best for folding reduced BPTI in comparison with GSH/GSSG where BPTI is
folded to 90% native protein in 48 h with 5 mM GSH and 5 mM GSSG.42 The
folding intermediates that accumulated during folding with aromatic thiols and
their corresponding disulfides were not the same as those observed with
GSH/GSSG (N' and N*).
4.3 Results
Three different p-substituted aromatic thiols 27, 9, 1 and their
corresponding disulfides 28, 10, 5 were chosen for the preparation of redox
buffers to fold reduced BPTI50,97–99,105 (Figure 4.2). These thiols and disulfides
were selected as the pKa values of the thiols are charged at neutral pH to similar
to the pKa value of solvent exposed thiol of PDI (6.7).106 These compounds
enhance water solubility. Both positively and negatively charged thiols were
selected to examine the effect of charge on protein folding at physiological pH.
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The

protein

folding

experiments

with

aromatic

thiols

and

their

corresponding disulfides were performed at pH 7.3 using 30 µM of reduced
BPTI.107 Variable concentrations of disulfides and thiols were used for the
preparation of the redox buffer along with 0.20 M KCl, 0.10 M bis-tris-propane,
and 1 mM EDTA. The folding experiment was run at 25°C under argon.107,108 The
reactions were quenched with formic acid at six different time points by removing
300 µL aliquots from the reaction mixture at each time point.107 Each aliquot was
analyzed by reverse phase HPLC.93 A pH of 7.3 was selected to mimic
physiological conditions of protein folding and to compare the results with
previously reported work.67,93,109 The curve of percentage native protein formed
versus refolding time was plotted for every experiment performed and compared
to other conditions. The highest percentage of native protein formed in the
shortest time without observed protein precipitation was considered the best
condition. Finally, the result was compared to the optimal conditions of the
traditional folding buffer GSSG/GSH (5 mM/5 mM).42
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Figure 4.2. Different aromatic thiols and their corresponding disulfides. 27:
phosphonic acid thiol (PA); 28: phosphonic acid disulfide; 9: sulfonic acid thiol
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(SA); 10: sulfonic acid disulfide; 1: quaternary ammonium salt thiol (QAS); 5:
quaternary ammonium salt diuslfide.50,97–99,105
4.3.1

Folding

with

negatively

charged

aromatic

thiols

and

their

corresponding disulfides
Two different negatively charged aromatic thiols, phosphonic acid thiol
(PA) 27 and sulfonic acid thiol (SA) 9, were selected to study the folding of
reduced BPTI. Thiol 27 has two negative charges and thiol 9 has one negative
charge.

Initially,

reaction

mixtures

were

prepared

by

adding

selected

concentrations of thiol 27 and its disulfide 28 to the folding mixture containing
reduced BPTI and bis-tris-propane buffer at pH 7.3. Two different concentrations
of disulfide 28 were chosen, 0.09 and 0.25 mM. The folding experiment was first
done using 0.09 mM disulfide 28 and 1 mM thiol 27. Protein precipitation was
observed almost immediately after protein folding started, as the solution became
cloudy. The precipitation was worse with higher concentrations of thiols.
Next, the folding of reduced BPTI was investigated using aromatic thiol 9
and its disulfide 10. For 0.09 mM disulfide 10 concentration, 1, 2, 5, and 10 mM
thiol 9 were investigated and for 0.25 mM concentration of disulfide 10, 1, 2, 5,
and 10 mM thiol 9 were investigated. A reaction mixture containing 0.25 mM of
disulfide 10 in combination with 1 mM of the thiol 9 folded BPTI to 82% while a
reaction mixture with 2 mM thiol achieved 91% in 6 h. With 5 mM and 10 mM
thiol 9, more than 90% native protein was obtained within an hour. With thiol 9
and 0.25 mM disulfide 10, all combinations of redox buffer precipitated protein.
The concentration of disulfide 10 was reduced and used 0.125 mM to see if
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protein precipitation was reduced. No precipitation was with 2 mM thiol 9 and
folding was almost complete in 8 h forming 95% native BPTI. While with 5 mM
thiol 9, 92% of native BPTI was formed in 4 h; however, protein precipitation was
observed at about 6 h. The 1 mM thiol was not used as folding was slower with 2
mM thiol and also the 10 mM thiol was not used as protein was precipitated with
5 mM thiol. The concentration of the disulfide 10 was further reduced to 0.09 mM
and used it in combination with 1, 2, 5, and 10 mM thiol 9. With 5 and 10 mM
thiol 9 (Figure 4.3). The folding yield was higher with higher concentration of
thiols and folding was faster too.
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Figure 4.3. Folding of reduced BPTI with 0.09 mM disulfide 10 and different
concentrations of thiol 9.
The protein area obtained from the analysis is shown in Figure 4.4 which
showed that 0.09 mM of disulfide 10 with all concentrations of thiol 9, areas of
total protein is lower than the expected. However, 0.09 mM of disulfide 10 and 1
mM of thiol 9, area of protein is very close to expected value, as there is no
observed protein precipitation. Therefore, 0.09/1 mM disulfide/thiol combination
is the best condition for these sets of experiments. The overall conclusion from
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these folding experiments using negatively charged aromatic thiols and their
corresponding disulfides was that the protein precipitates. Therefore, to fold basic
proteins like BPTI faster and to obtain higher yield at shorter time, these thiols
should not be considered.

Figure 4.4. Total area of protein in different folding conditions with thiol 9 and
disulfide 10.
4.3.2 Folding with positively charged aromatic thiol 1 and its corresponding
disulfide 5
It was proposed that a positively charged small molecule thiol would
increase the net positive charge in the mixed disulfide or between the positively
charged protein and small molecule and thus increase solubility. With negatively
charged small molecules, the net charge of the mixed disulfide between the small
molecule and positively charged protein is decreased. For this purpose,
quaternary ammonium salt (QAS) thiol 1 and its disulfide 5 were used. Two
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different disulfide concentrations, 0.09 mM and 0.25 mM, were first selected to
optimize the condition. Eight different conditions of folding buffer were prepared
using 0.09 and 0.25 mM disulfide 5 concentrations with 1, 2, 5, and 10 mM thiol
1. The results are shown in the following Figures 4.5 and 4.6. With 1 mM thiol 1,
90% folded protein was observed in 4 h. With 2 mM thiol 1, 95% folded protein
was observed in 2 h. With 5 mM and 10 mM thiol 1, folding resulted in more than
90% native protein in 1 h. In all these conditions, protein precipitation was not
observed. Comparing these conditions, 0.25 mM of disulfide 5 with 5 and 10 mM
of thiol 1 were our best conditions for folding reduced BPTI. In these
experiments, the drawbacks of folding with QAS were the decrease of native
protein percentage with higher thiol concentrations (Figures 4.5 and 4.6) and the
increase in total protein area (Figure 4.7) with higher time points. Adventitious
oxidation of thiol 1 was observed to be a problem at longer time points (Figure
4.8). I hypothesized that this was the reason for the described drawbacks.
Therefore, thiol oxidation needs to be controlled for better results.
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Figure 4.5. Folding of reduced BPTI with 0.09 mM disulfide 5 and different
concentrations of thiol 1.
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Figure 4.6. Folding of reduced BPTI with 0.25 mM disulfide 5 and different
concentrations of thiol 1.

Figure 4.7. Total area of protein in different folding conditions with thiol 1 and
disulfide 5.
Two intermediates were seen during the analysis with retention times of
38 min and 42 min, the amount of these intermediates decreased with the
refolding time (Figures 4.9 and 4.10). These intermediates are promising for the
determination of rate constants in the future.
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Figure 4.8. Oxidation of thiol 1 in different folding conditions with thiol 1 and
disulfide 5.
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Figure 4.9. Prominent intermediate during folding of reduced BPTI with 0.25 mM
disulfide 5 and thiol 1 at 38 min.
Different experiments were performed to minimize the oxidation of thiol 1
and to achieve a consistent protein area over different time points. When the
reaction without protein was run, the oxidation of thiol 1 was observed, indicating
poor quenching. The reaction with 5 mM thiol 1 only was also run and quenched
with different concentrations of different acids and observed that 80 µL HCOOH
was the best to quench the 300 µL reaction mixture (Figure 4.11).
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Figure 4.10. Prominent intermediate during folding of reduced BPTI with 0.25
mM disulfide 5 and thiol 1 at 42 min.

Figure 4.11. Different quenching conditions.
The experiments were performed by mixing protein, thiol, disulfide, water
and buffer in different ways and found that mixing all components of folding
mixture in an argon environment reduced thiol oxidation dramatically. The QAS
reaction (0.25 mM disulfide 5 and different concentrations of thiol 1) was
repeated again with 4 h as the last time point. All solutions were bubbled with
argon before mixing and mixing itself was done with argon gas bubbling. The
result is summarized in graphical form (Figure 4.12).

65

100

Refolding
time
(min)
5
15
30
60
120
240

% Native protein

80
60
40

1 mM thiol
2 mM thiol
5 mM thiol
10 mM thiol

20
0

0

50
100 150 200
Refolding time (min)

250

1
mM

2
mM

5
mM

10
mM

21.2
40.0
54.7
71.8
87.8
95.9

34.3
52.0
68.2
86.1
94.9
95.1

46.6
72.7
86.5
95.2
95.4
94.1

56.0
74.9
91.4
95.4
95.5
96.6

Figure 4.12. Folding of reduced BPTI with 0.25 mM disulfide 5 and different
concentrations of thiol 1.
Although the thiol oxidation was diminished, it was still observed that the
total protein area was going up with higher time points. I proposed that the
waiting time before the injection in HPLC was causing the increase in the total
area of protein. Therefore, reactions were quenched at 5 min utilizing three
different methods: analyzed by immediate injection, injection after few hours
storing in ice bath, and inject next day storing at -20oC. It was found that total
protein area in all samples had a close range of total area (Figure 4.13). In the
previous experiments, where samples waited in the HPLC auto sampler for a
long time before injection, the total protein area increased. However, the storage
time for these samples were too long due to longer analysis time of HPLC which
took 110 min for one sample. To minimize the storage time, the HPLC analysis
time was decreased to 40 min by changing the HPLC gradient to 90% solvent A
in 0 min and 60% solvent A in 40 min. Aliquots after quenching were stored at
4oC before being injected into the HPLC. With the new program, the maximum
waiting time was 2 h.
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Figure 4.13. Analysis of total protein area with different storage methods.
Then, folding reactions were run containing 0.25 mM disulfide 5 and 1, 2,
5, and 10 mM thiol 1 concentrations to see the effect. It was observed that total
protein area was consistent and almost no thiol oxidation was observed (Figure
4.14). It was also observed that the native protein percentage was not going
down with higher time points. It was concluded that the decrease in native protein
percentage was because of the increase in total protein area with longer time
points. The problem of decreasing native protein percentage was solved through
the series of experiments. It was observed that reduced BPTI folds to more than
90% native BPTI within an hour (Figure 4.15). Likewise, there was no protein
precipitation with any concentrations of thiol 1 and disulfide 5. The observation
showed that the protein’s total area was close to the area of native protein. It was
concluded is that 0.25 mM disulfide 5 and 10 mM thiol 1 give the best results.
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Figure 4.14. Total protein area in new HPLC method.
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Figure 4.15. Folding of reduced BPTI with 0.25 mM disulfide 5 and different
concentrations of thiol 1.
The problem associated with new HPLC method was that the intermediate
peaks were not well resolved. This did not cause any problem for the overall
results because the focus was only on the folding yield of protein (Figures 4.16,
4.17, 4.18, and 4.19).
Then 10 mM thiol 1 was used and changed the disulfide 5 concentrations
from 0.25 mM to 1 mM and 5 mM to see the effect. With 1 mM disulfide 5, the
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result was very close to 0.25 mM, but with 5 mM disulfide concentration, the
result was worse (Figure 4.20).
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Figure 4.16. Chromatogram showing native protein and intermediates with 0.25
mM disulfide 5 and 10 mM thiol 1.

Figure 4.17. Chromatogram showing native protein and intermediates with 0.25
mM disulfide 5 and 1 mM thiol 1.
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Figure 4.18. Chromatogram showing native protein and intermediates with 0.25
mM disulfide 5 and 2 mM thiol 1.

Figure 4.19. Chromatogram showing native protein and intermediates with 0.25
mM disulfide 5 and 5 mM thiol 1.
Then the folding of BPTI was compared using QAS with that of
GSSG/GSH. The results indicated that QAS is better than GSSG/GSH for folding
reduced BPTI in terms of time and yield (Figure 4.21).
From the folding results with reduced BPTI and positively charged
aromatic thiol, QAS, and its corresponding disulfide, it was found that 0.25 mM
QAS disulfide with 5 and 10 mM of its thiol as a redox buffer were the best
conditions for BPTI folding. In this condition, BPTI can fold within 1 h to over
90%. Therefore, the method improved significantly over the traditional method of
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BPTI folding using GSSG/GSH, which needed 48 h to fold to 90%. To conclude,
with the thiols that have negatively charged para-substituents, protein
precipitation was observed resulting in the loss of protein. In addition, protein
folding was slower than QAS.
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Figure 4.20. Folding of reduced BPTI with 10 mM thiol 1 and different
concentrations of disulfide 5.
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Figure 4.21. Comparison of folding of reduced BPTI with our optimal condition
(10 mM thiol 1 and 0.25 mM disulfide 5) with optimal condition of traditional buffer
(5 mM GSH and 5 mM GSSG).
4.4 Discussion
Our hypothesis was that a redox buffer composed of aromatic thiol and
the corresponding disulfide would fold protein faster than a redox buffer
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composed of aliphatic thiol and the corresponding disulfide. To demonstrate the
dramatic increase in the folding rate of reduced BPTI with a redox buffer
composed of aromatic thiols and corresponding disulfides, three different
aromatic thiols and corresponding disulfides were selected. The pKa of these
thiols, their structure, and pH of the solution were considerefor the selection.
Aromatic thiols have good nucleophilic character, and are better leaving groups
than glutathione at physiological pH.94,110 Thiolates of aromatic thiols 27, 9, and
1; and glutathione thiolate have approximately equal nucleophilic character, but
at physiological pH, large proportions of glutathione (pKa = 8.7) is in its inactive
thiol form while large proportions of aromatic thiols 27, 9, and 1 (pKa = 5.5-5.7)
are in their thiolate form.48 Previous work showed that at neutral pH, the
observed rate constant of the reaction with aromatic thiol is 6 times faster than
glutathione, a small molecule aliphatic thiol, and its disulfide.49 Therefore, at pH
7.3, thiolates of thiols 27, 9, and 1 are expected to react faster than glutathione.
The leaving group ability of any thiol is inversely proportional to its pKa
values.48,94 Hence, thiolates of 27, 9, and 1 are better leaving groups than
glutathione as their pKa values are lower.
During in vitro protein folding with a redox buffer containing small molecule
aromatic thiols and disulfides, there are eight possible mechanisms of thioldisulfide interchange reactions, six of them are shown in scheme 4.2 where I-IV
involves small molecules as a nucleophile and III-VI involve the small molecules
as a central thiol.38,49 The thiolate from an aromatic thiol can attack a protein
disulfide (reaction I), a small molecule disulfide (reaction IV), or a mixed disulfide
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between the small molecule and protein (reaction II and III). In reactions, I-IV,
these thiolates act as a nucleophile whereas in reactions, III-VI, the small
molecule thiols act as a central thiol. In reaction V, the aromatic thiol acts as both
a leaving group and a central thiol. Reactions I, III, V, and VI show a net change
in protein disulfide bonds. Therefore, aromatic thiols are expected to involve in
rate limiting steps in reactions I, III, V and VI. The rate constants for these
reactions are expected to be greater than with glutathione.
Scheme 4.2 Reactions of aromatic thiol as a nucleophile and/or central thiol in a
redox buffer

Reduced BPTI was folded using redox buffers composed of one of three
different aromatic thiols, QAS, PA, or SA and its corresponding disulfide. It was
determined that the redox buffer composed of the positively charged aromatic

73

thiol, QAS thiol, and its disulfide could fold reduced BPTI faster and more
efficiently than redox buffers composed of negatively charged SA thiol/disulfide
or PA thiol/disulfide. The decrease in the folding yield of native BPTI from
reduced BPTI with a redox buffer composed of 27 and 28 or 9 and 10 was
proposed to be due to the decrease in net positive charge of unfolded BPTI as
these negatively charged small molecules form mixed disulfides with reduced
BPTI and decrease the net positive charge of BPTI (Figure 4.22). The result is
the formation of aggregation. Therefore, to increase in the folding yield of BPTI, a
decrease in aggregation is required.111
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Figure 4.22. Effect of negatively and positively charged thiols on net charge of
BPTI.
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Positively charged quaternary ammonium thiol 1 and its disulfide 5 were
used to prepare a redox buffer. The use of a positively charged thiol and disulfide
will result in an increase in the net positive charge of reduced BPTI so that
folding goes smoothly and rapidly. The results obtained from the folding of
reduced BPTI using QAS thiol 1 and its disulfide 5 at pH 7.3 proved that a redox
buffer composed of an aromatic thiol and corresponding disulfide increases the
rate of folding dramatically relative to glutathione at their optimal conditions. Also,
positively charged thiols and disulfides are better for BPTI folding. It is also
noteworthy that thiols with lower pKa values undergo the thiol disulfide
interchange reactions faster hence increasing the rate of formation of native
protein at their optimal concentration. At higher thiol/disulfide concentrations, the
folding rate of BPTI decreases.
To conclude, folding of reduced BPTI increased dramatically in the
presence of a redox buffer composed of positively charged aromatic thiol QAS
and its corresponding disulfide as compared to traditional redox buffer composed
of glutathione/glutathione disulfide. The folding with QAS thiol and its disulfide
took about an hour to fold reduced BPTI to 90% while glutathione/glutathione
took about 48 h to fold reduced BPTI to 90%. The optimal condition of QAS thiol
was 10 mM and disulfide was 0.25 mM at pH 7.3. Use of thiols/disulfides with
negatively and positively charged groups allowed us to understand their effect on
protein precipitation. For BPTI, use of positively charged thiols/disulfides with
pKa close to that of free thiol of PDI helps to fold BPTI rapidly in high yield.
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4.5 Experimental section
4.5.1 Materials
The protein used for the folding study, BPTI, was purchased from Roche
Applied Science under the trade name Aprotinin and was used to prepare
reduced BPTI directly. Trizma base, guanidinium chloride (GdnHCl), bis-tris
propane, EDTA, potassium chloride (KCl), dithiothreitol (DTT), GSH, and GSSG
were purchased from Sigma-Aldrich. SephadexTM G-25 Fine was purchased from
GE Healthcare and made wet for 24 h with 0.01 N HCl before packing the
chromatographic column. Trifloroacetic acid (TFA) and acetonitrile (ACN) were
HPLC grade and were purchased from Fischer Scientific. Concentrated
hydrochloric acid was also purchased from Fischer scientific. Nanopure
deionized water was prepared using a Branstead D3750 and was deoxygenated
by bubbling argon for 30 min through it before using in each experiment.
Aromatic thiols 27, 9, and 1 and their corresponding disulfides 28, 10, and 5 were
prepared as described previously. The UV-Vis spectra were measured using a
Cary 300 spectrophotometer. The HPLC analysis was performed on a Hitachi D7000 system, which was connected with a L-7400 UV-Vis detector and a column
oven. The pH measurements were done using a VWR symphony SB20 pH meter
which was calibrated before its use. BPTI was lyophilized using a Labconco
FreeZone 2.5 L Benchtop freeze dryer. The columns used for reverse phase
HPLC (RP-HPLC) were an Alltech Macrosphere C18 preparative column (250 ´
22 mm); a Vydac C18 semi-preparative column (250 ´ 10 mm); and a Vydac C18
analytical column (250 ´ 4.6 mm).
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4.5.2 Preparation of reduced BPTI
Reduced BPTI was prepared from Aprotinin in Trizma buffer using
reducing agents. The Trizma buffer was prepared by dissolving Trizma base, KCl
and EDTA in deionized water. The pH of the buffer was adjusted to 8.7 using
concentrated HCl. The solution was prepared on a 100 mL scale by maintaining
the final concentration of Trizma as 0.01 M, KCl 0.20 M, and EDTA 1.0 mM. The
reduction mixture was prepared in a 15 mL centrifuge tube using Trizma buffer in
which GdnHCl and DTT were added. The volume of 10 mL was prepared by
maintaining the final concentration of GdnHCl 6 M and DTT 0.05 M. The solution
was equilibrated in 25°C water bath before its application. Aprotinin was added to
the reduction mixture at a concentration of 6.5 mg/mL. The resulting mixture was
kept at 25°C in a water bath for 1 h to reduce BPTI followed by the addition of 0.2
N HCl to adjust the pH between 2-3 and quench the reduction. The reduced BPTI
was then purified by gel filtration on a sephadex G-25 ccolumn using 0.01 N HCl
as

the

mobile

phase.

The

fractions

were

analyzed

by

a

UV-Vis

spectrophotometer at 280 nm. The fractions that contain reduced BPTI were
combined and then lyophilized before further purification by HPLC. The dried
reduced BPTI was then dissolved in 0.01 N HCl and purified by RP-HPLC on a
C18 preparative column. The mobile phase used was a mixture of solvent A
(0.1% TFA in water) and solvent B (90% acetonitrile with 0.1% TFA in water).
The elution gradient used was 0 min, 90% solvent A; 20 min, 65% solvent A; 100
min, 61% solvent A; 120 min, 50% solvent A with a flow rate of 5 mL/min. The
fractions containing reduced BPTI were identified by absorbance at 280 nm. The
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fractions were then further analyzed using a Vydac C18 analytical column by
monitoring the absorbance at 229 nm. The flow rate of 1 mL/min was used with
the elution gradient of 0 min, 90% solvent A; 15 min, 73% solvent A; 35 min, 71%
solvent A; 50 min, 69% solvent A; 70 min, 65% solvent A. The pure reduced
BPTI was then lyophilized and dissolved in 0.01 N HCl to prepare a stock
solution of concentration 1 mg/mL. The stock solution was stored in -20°C before
use.
4.5.3 Oxidative folding of reduced BPTI
To start a folding reaction, 1.5X folding buffer was first prepared. In 80 mL
deionized water, 4.234 g of bis-tris propane, 2.236 g of potassium chloride (KCl),
and 0.0558 g of EDTA were dissolved and the pH was adjusted to 7.3 with
concentrated HCl. Then, deionized water was added until the volume was 100
mL in a volumetric flask. The buffer was deoxygenated by passing argon gas
through it for 30 min. The thiols and their corresponding disulfides were purified
using a Vydac C18 semi-preparative HPLC column heated to 50°C before using
them in a folding buffer. Injection of samples was done manually, 2 mL at a time,
and a flow rate of 3 mL/min was utilized. The gradient used was 0 min, 90%
solvent A; 15 min, 75% solvent A; 35 min, 73% solvent A; 50 min, 72% solvent A;
100 min, 65% solvent A. The absorbance was monitored at 252 nm. Pure
fractions of thiols and disulfides were collected, lyophilized, dissolved in
deoxygenated buffer, and kept at -20°C before use. The final folding buffer for
the reaction contains 0.10 M bis-tris propane, 0.20 M KCl, 1.0 mM EDTA, and
indicated concentration of aromatic thiols and their corresponding disulfides.
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Folding reactions were conducted under argon at 25°C. At each specific time, a
300 μL aliquot was removed and quenched by the addition of formic acid. Initially
20 μL formic acid was used but it was found from experiments done to improve
folding efficiency that 80 μL formic acid quenched better than 20 μL, therefore, I
used 80 μL in later experiments. Each aliquot was analyzed by RP-HPLC on a
Vydac C18 analytical column. A flow rate of 1 mL/min was used. For the
traditional HPLC analysis method, linear gradient was used: 0 min, 90% solvent
A; 15 min, 75% solvent A; 35 min, 73% solvent A; 50 min, 72% solvent A; 110
min, 70% solvent A. The absorbance was monitored at 229 nm and the column
temperature was maintained at 50°C. All peak areas were summed and the total
area was assigned a value of 100%. An improved HPLC analysis method was
developed for the faster analysis of samples. The flow rate was 1 mL/min and
elution gradient used was 0 min, 90% solvent A; 40 min 60% solvent A.
4.6 Conclusion
Folding of reduced BPTI was investigated using both negatively and
positively charged aromatic thiols/disulfides. With the redox buffer composed of
negatively charged thiols, phosphonic acid thiol and sulfonic acid thiol, and their
corresponding disulfides BPTI was precipitated during folding. Therefore, the
conclusion was that the negatively charged aromatic thiols and their
corresponding disulfides are potentially poor folding agents for basic proteins.
With the positively charged thiol, QAS, and its disulfide as the redox buffer,
reduced BPTI was folded without precipitation and reached 90% native form
within an hour. The area of native protein and total protein area were consistent
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with no protein precipitation. The percentage of native protein in 1 h time point
was highest with 10 mM thiol, and 0.25 mM QAS disulfide.
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CHAPTER 5
Targeted Molecular Dynamics (TMD) simulation study for conformational
folding from the [5-55] like conformation to the native conformation of BPTI
5.1 Abstract
Oxidative folding of extracellular proteins includes conformational folding
and disulfide bond formation which are coupled to each other during the folding
process until the formation of the native protein structure. Therefore,
conformational changes of these secreted proteins during folding play an
important role in the formation of native disulfide bond and to complete the
folding process. Targeted molecular dynamics (TMD) was used to study the
conformational changes and the formation of disulfide bonds in bovine pancreatic
trypsin inhibitor (BPTI) as a model protein containing disulfide bonds. The initial
structure was constructed with Cys5 and Cys55 close enough to form a disulfide
bond but all other cysteines are far apart and not close enough to form disulfide
bonds. The TMD simulations were carried out in two different ways and
investigated the conformational changes during the simulation. The folding
process and the formation of the native protein was studied using visual analysis,
evolution of secondary structure, disulfide bond formation, RMSD calculation,
radius of gyration, and hydrogen-bond formation. With the initial simulation,
targeting all atoms of the initial structure, it was found that conformational
changes played an important role in the formation of the disulfide bonds as seen
for the decrease in distance of Cys14-Cys38 which was not observed until the
last stage of the TMD. The formation of the kinetic traps N' and N* were not
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observed during our initial simulations. The final native conformation was
obtained once the correct antiparallel β-sheets and subsequent Cys14-Cys38
distance came closer to form disulfide bond. In the second simulation, targeting
only alpha carbons and sulfur of cysteines of the starting structure to the final
structure, formation of native protein was achieved via the formation of N*
followed by NSH. The Cys14-Cys38 distance was decreased to a value close to
S-S distance value and observed increased many times until the final native
structure was formed.
5.2 Introduction
Folding studies of disulfide containing proteins are significant because of
the diseases associated with misfolded proteins containing disulfide bonds.112
Experimentally, folding studies are performed by quenching the folding reaction
at various stages and studying the formation of disulfide bonds.19,86 The
conformational changes of these intermediates are difficult to determine with
experimental procedures alone.113 Therefore, highly standardized computational
methods are required to complement the experiments and understand the
formation of disulfide bonds and protein folding.85,114
Molecular Dynamics (MD) computational simulation is a valuable tool for
investigating conformational changes of macromolecules because it can give
atomic level details of conformational changes.115 Examples of TMD simulations
used to study conformation changes include the conformational changes during
the opening and closing of GroEL to unravel its ATP binding mechanism116,
transition from open form to closed form of ion channels to understand their
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function as a ion transport such as KcsA potassium ion channels117,118, and
structural changes of the C-terminal domain (CTD) from α-form to β-form of
RfaH.119 Targeted molecular dynamics (TMD) is a robust simulation tool used to
examine the process of transition from one conformation to another at normal
temperature, reducing the distance continuously to the target confirmation by
applying time dependent geometrical constraint.120 During TMD, the root mean
square distance (RMSD), which is a measure of physical distance between two
structures, to the target is continuously reduced; the system forces initial state to
find the path to final state; and the Cartesian distances between the
conformations describes the progress of reaction.121 The RMSD between the
current coordinates and the target structure is computed in every time step by
aligning the target to the current coordinates. Reasons of calculating RMSD are
to find out the time point when conformation changes and to define the folding
procedure. The following equation is used to calculate the force on each atom.
!"#$ = [ # &'() * -,-./ * ]$ … … … … … … … . . (1)
$%

where, !"#$ % is the instantaneous best-fit RMSD of the coordinates of simulated
initial structure from the coordinates of targeted structure, and !"#$ % is the
linear distance from initial RMSD at the first TMD step to the final RMSD at the
last TMD step.89 The symbol ! is the spring constant which is scaled down by the
number ! of the targeted atoms.
Herein, the formation of disulfide bonded like intermediates along with the
conformational changes was studied using bovine pancreatic trypsin inhibitor
(BPTI) as a model protein, which contains 58 residues with three disulfide bonds.
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Experimental work by Creighton86 on the renaturation of reduced BPTI showed
that the non-native single-disulfide like intermediates were formed closing Cys5
and Cys30, Cys30 and Cys55, and Cys5 and Cys51 in 1/4th of the total isolable
intermediates. Later, Weissman and Kim reexamined the folding of the reduced
BPTI65 using improvised techniques such as acid quenching (quenching
technique) and reverse phase high-performance liquid chromatography (HPLC)
(separation technique) and found that only the native-like disulfide bonds were
present in the isolated intermediates. Simulation study using a lattice model85
and theoretical study using proximity rule122 showed that non-native type disulfide
bonds were formed transiently. However, only the intermediates with native type
disulfide bonds were formed during the later stages of folding.
Targeted MD was used to study to see the effect of conformational
changes in disulfide bond formation starting with the [5-55] like intermediate of
BPTI, which is challenging to perform experimentally. The crystal structure of
native BPTI was obtained from the protein data bank (PDB ID: 4PTI). The
conformation was modified with pymol123 so that only the Cys5-Cys55 distance
was close enough to form bond and all the other native Cys-Cys were far apart.
Some important structural criteria (proximity and orientation of cysteine residues)
of folding required by disulfide containing proteins were considered during the
selection of the starting structure. Starting from the modified structure, TMD was
performed, targeting the initial structure to the final native structure in explicit
water. TMD was selected because it can provide important information on
conformational changes and molecular motions that are hard to study in shorter
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computational times.119 BPTI has been extensively used as a model system in
many molecular dynamics simulation studies.80,124 However, to the best of our
knowledge, our work represents the first investigation of the conformational
changes in BPTI using TMD simulations. The conformational changes in BPTI
during the folding was investigated and compared the results with previous MD
simulations and experiments.
5.3 Methods
The x-ray structure of native BPTI was obtained from the crystal structure
of BPTI in the protein data bank (PDB ID: 4PTI). The starting structure containing
all cysteine residues but without the presence of actual disulfide bond in the
structure was constructed. Cysteine 5 and 55 were close enough in the model to
form disulfide bond. All atoms were used during simulation. The change in the
conformation of [5-55] to native structure was first simulated in explicit solvent
with CHARMM36 force fields.125
5.3.1 Molecular dynamics (MD) setup for equilibration and TMD
The initial, [5-55] like structure for running TMD was prepared from the
native structure obtained from the protein data bank (PDB ID: 4PTI). By manually
adjusting some of the dihedral angles, we obtained an open form structure from
the native structure which still retains the secondary structural elements. The
resulting protein structure was solvated in the rectangular box of water molecules
having minimum solute-wall distance of 10 Å with TIP3 water. The system was
neutralized by adding chloride ions using Monte-Carlo ion placing method. I
added 0.15 M KCl which generated 30 positive and 36 negative ions. CHARM-
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GUI126 web-server was used for solvation and preparation of the input files
needed for simulations. The dimension of the simulation box was 80×80×80 Å3
with the total number of 34828 atoms in the system. Molecular dynamics (MD)
simulations were performed with CHARM36125 force field using NAMD.127 The
particle mesh Ewald method128 was used to calculate long range interactions
using a 12 Å nonbonded cutoff. The energy minimization was done for 20 ps.
The temperature of the system was maintained at 303.15 K using Langevin
dynamics with a damping coefficient of 1 ps-1. The system was energy minimized
for 20 ps and equilibrated for 180 ps with NPT run using 2 fs integration time
step. The RATTLE and SETTLE algorithms were used to restrain protein bonds,
and to maintain water geometry respectively. A 1 ns production run was
performed, followed by a TMD run for 15 ns. A biasing force of force constant per
atom of !"#$% = (' = 0.589 kcal/ (mol Å2) was used for the TMD simulation.
5.4 Results and discussion
The native structure of BPTI has two α-helix, two β-strand, and three
disulfide bonds as shown in Figure 5.1. The first α-helix (H1 in the figure 5.1) has
one and a half turns from Asp3 to Leu6 and is close to the N terminus. The
second α-helix (H2 in the figure) has three turns from Ala48 to Gly56 and is close
to the C terminus. The first β-strand (B1 in the figure) lies from Ile18 to Asn24
and second β-strand (B2 in figure) lies from Leu29 to Tyr35. These two β-strands
are anti-parallel to each other. Three disulfide bonds (5-55), (14-38), and (30-51)
make the tertiary structure of BPTI stable by linking the secondary structures.
The maximum dimension of native BPTI is 30 Å.59
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Figure 5.1 Native structure of BPTI showing α-helices (in red), β-strands (in
green), disulfide bonds (in yellow), and loops and turns (in blue).59,88 The crystal
structure is taken from protein data bank (PDB ID: 4PTI).
The topology of BPTI looks like a piece of string folded twice by itself as
shown in Figure 5.2. This simplified structure indicates that the (5-55) disulfide
bond joins the two terminal α-helices, the (14-38) disulfide bond joins the two βstrands near the loose end of β-hairpins. The third disulfide bond (30-51)
connects the three turn α-helix (H2) with the β-sheets; therefore, the compact
native structure of BPTI is formed.
5.4.1 TMD using all atoms
5.4.1.1 Changes in structural configuration of BPTI during TMD
The [5-55] like initial structure is an open form BPTI which has the rmsd of
15 Å compared to the native structure. Targeted MD simulations of 5, 10, and 15
ns length were performed and each resulted in the conversion of the [5-55] like
initial structure to the native structure of BPTI. The process of conversion of the
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one disulfide intermediate [5-55] to N is shown in Figure 5.3, where snapshots
taken at various stages of structural transformation demonstrate the protein’s
conformations at respective stages.

(14-38)

B2

B1

(30-51)
(5-55)

H1

H2

N

C

Figure 5.2 The secondary structure of BPTI with its three disulfide bonds.59,88
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Figure 5.3 Snapshots of conformations formed at different stages of
conformational changes during conformational folding of BPTI using TMD
simulation. Sulfur atoms of cysteines are shown in yellow balls.
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The graph of the evolution of the secondary structures as a function of
time during the TMD simulation is shown below in Figure 5.4. We found that the
residues 18-24 transforms from a coil/turn/loop-to a β-strand after 14 ns of
simulation, which occurred after decreasing S-S distance of Cys30 and Cys51 to
the value close to native bond. Similarly, for residues 28-36, and 44-46, in which
turn/loop/coli-to-β-strand transitions were observed after decreasing S-S distance
Cys30 and Cys51 close enough to form a bond (Figure 5.4). All other residues do
not show secondary structure changes during the simulation.

Figure 5.4 Evolution of secondary structure from TMD simulations of BPTI [(555) to N].
5.4.1.2 Distance between CYS residues of the native disulfide bonds
With the use of TMD, the conversion of a single disulfide containing
intermediate, [5-55] to native BPTI, [5-55, 14-38, 30-51], was achieved on a 15
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ns time scale. Within 2.5 ns, the Cys30-Cys51 distance was decreased to 5.3 Å
with from 21.5 Å in the starting structure. On the other hand, the Cys5-Cys55
distance was increased to 11.3 Å within 2 ns from 3.73 Å in the starting structure.
The Cys30-Cys51 distance was seen closing and then increasing multiple times
before a compact structure of BPTI was obtained. Formation of compact native
conformation was observed at the late stage of simulation. The Cys14-Cys38
distance was decreased close to real S-S bond distance after the formation of
NSH [5-55, 30-51] like conformation, which proved the experimental finding that
NSH rearranges rapidly to N (Figure 5.5).
22
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Figure 5.5 Distance between sulfur atoms in native disulfide bonds.
5.4.1.3 Root mean square deviation during TMD
The root mean square deviation (RMSD) was computed from the atomic
trajectories for targeted MD run. The plot of the RMSD of all backbone and heavy
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atoms in the TMD-simulated structure relative to the corresponding target
structure is shown in Figure 5.6. The result showed that all backbone atoms and
heavy atoms used in our TMD simulations reached the target structure within 15
ns (with the accuracy of 1 Å). The initial RMSD of 8.7 Å at first trajectory
continuously decreased to 1.12 Å at 3000th trajectory forming the native
structure.

Figure 5.6 Change in RMSD during TMD of BPTI.
5.4.1.4 Analysis of intermediates with the change in radius of gyration
The relationship between the conformational changes and the folding was
studied by taking and analyzing snapshots of folding trajectories as depicted in
Figure 5.7. The initial structure, with Cys5 and Cys55 distance close enough to
form bond, had a radius of gyration (Rg) of 14.1 Å, was targeted to native
structure as targeted MD simulation was started, and observed that Rg was
reduced to 11.4 Å. The β-sheets and α-helices were already present in the initial
structure. The folding was proceeded by crumpling up of the β-strands and
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subsequent ordering. The folding was proceeded with the rearrangement of
starting structure to a non-native conformation [51-55] followed by formation of
[5-51]. During the process, Cys5-Cys55 distance was decreased and then
increased time and forth which promoted to decrease the distance between
Cys30 and Cys51. The distance of Cys30 and Cys51 was also seen decreasing
and then increasing many times rearranging to some non-native like
intermediates and compacting the structure of protein. The Cys5-Cys55 distance
was decreased to form bond followed by the decrease in Cys30-Cys51 distance
which lead to the formation of conformation of NSH. After the flipping of the Cys30
and Cys51 residues, correct antiparallel β-strands formation took place followed
by rapid closeness of Cys14-Cys38 distance leading to the compact structure of
BPTI was observed. The most interesting observation during our simulation was
the absence of N' and N* which were key intermediates formed during oxidative
folding of BPTI. Once the antiparallel β-strands were seen formed correctly
during the late stage of the simulation (after the decrease in Cys30-Cys51
distance close to the bond real length), immediate decrease in the Cys14-Cys38
distance was observed that ultimately led to the native structure of BPTI. An
important observation here is that the structure of NSH is very close to the native
form structure, and that Cys14-Cys38 distance is the last to come close enough
to form a bond during the folding process of BPTI. The observations are
consistent with experimental findings.
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Figure 5.7 Folding trajectories demonstrating the BPTI folding pathway from [555] conformation to folded native state. The curve shows the decrease in the
radius of gyration (Rg) with respect to folding time. Some of the conformations of
trajectory (a-j) were shown to show how Rg decreases along with the progress of
folding.
5.4.1.5 Analysis of the folding trajectories
In folding trajectory analysis, the complete unfolding of a conformation of
single disulfide intermediate, [5-55], was found followed by the formation of single
non-native intermediate [51-55]. Then, [51-55] was rearranged to another nonnative like single disulfide intermediate [5-51]. The [5-51] intermediate was then
rearranged to native single disulfide intermediate [30-51] which was found to be
broken and formed several times. The decrease of Cys30-Cys51 distance for the
last time flips one of the β-strand leaded the formation of native two-disulfide
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intermediate NSH. The NSH was converted immediately to N due to the closeness
of Cys14-Cys38 residues. Figure 5.8 demonstrates the transformation to target
structure via the formation of different conformations.

Initial structure

[Native]

[51-55]

[5-51]

[NSH]

[30-51]

Figure 5.8 Snapshots of different conformations formed during TMD simulation of
[5-55] like conformation of BPTI to native like BPTI. Sulfur atoms of cysteines are
shown as yellow balls.
5.4.2 TMD using Cα and sulfur of cysteines (SG) only
5.4.2.1 Change in structural conformation during simulation
The change in conformation of BPTI during TMD simulation is as shown in
Figure 5.9 where the snapshots taken at different time points show the progress
of conformational changes from initial structure to the target structure. The 15 ns
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simulation targeting only Cα and SG atoms only was performed at this time as
opposed to targeting all heavy atoms in previous simulation. The transformation
to the native structure was achieved at around 13 ns simulation bringing
cysteines close to that distance as found in native disulfide bonds.
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9 ns

11 ns

13 ns

14 ns

15 ns

Figure 5.9 Snapshots of conformations formed at different stages of
conformational changes during conformational folding of BPTI using TMD
simulation. Sulfur atoms of cysteines are shown in yellow balls.
5.4.2.2 Root mean square deviation analysis
The root mean square deviation (RMSD) was computed from the atomic
trajectories for TMD run. The plot of the RMSD of alpha carbons and sulfur of
cysteine in the TMD-simulated structure relative to the corresponding target
structure is shown in Figure 5.10. The result showed that TMD simulations
reached the target structure within 15 ns. The initial RMSD of 8.70 Å at first
trajectory continuously decreased to 1.17 Å at 3000th trajectory forming the native
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structure which suggests that TMD successful to understand the conformational
folding mechanism.
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Figure 5.10 Change in RMSD during TMD.
5.4.2.3 Distance analysis of native disulfide bonds
The formation of native BPTI [5-55, 14-38, 30-51] from the starting
conformation [5-55] was achieved in 15 ns time scale. The Cys14-Cys38
distance was seen closing and then increasing multiple times during simulation.
Initially the Cys14-Cys38 distance was set 8.4 Å which was decreased to 3.4 Å
within 2 ns. At the meantime, Cys5-Cys55 distance was increased to 12.3 Å with
in 1 ns from 3.4 Å in the starting structure. The Cys30-Cys51 distance was
sharply decreased to 8.4 Å from 20.1 Å of starting structure within 1.5 ns, then
increased to 18.6 Å in 4 ns. It was then seen decreasing gradually. It was
observed that Cys5-Cys55 and Cys14-Cys38 distances decreasing and then
increasing multiple times to form a compact structure of BPTI. Formation of NSH
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took place transiently at 13 ns followed by the formation of N which proved the
experimental finding that NSH rearranges rapidly to N. Figure 5.11 shows the
closing and increasing the Cys5-Cys55 and Cys14-Cys38 distances for bringing
the Cys30 and Cys51 close to each other and for compacting the BPTI structure.
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Figure 5.11 Distance between sulfur atoms in native disulfide bonds.
Formation of few non-native intermediates were also observed in our
simulation as shown in Figure 5.12. The first non-native intermediate [51-55] was
supposed to form as Cys51-Cys55 distance was very small enough to form a
bond. At around 8.5 ns, the Cys30 and Cys55 were very close, then were Cys5
and Cys30. Rearrangement at this stage allowed formation of N* which
rearranged to NSH for a very short time and immediately went to N.
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Figure 5.12 Distance between cysteines during simulation.
5.4.2.4 Analysis of intermediates with the change in radius of gyration
The figure 5.13 shows the decrease in radius of gyration with folding time.
The snapshots of folding trajectories (a-j) at various steps of folding shows how
the folding of BPTI is related to the formation of disulfide bonds by considering of
radius of gyration. The starting structure has a radius of gyration (Rg) of 13.6 Å
which on TMD simulation reached the final native structure having Rg of 10.6 Å.
As folding proceeded, the collapse and subsequent ordering of β-strands was
observed. The folding was proceeded with the rearrangement of starting
structure to non-native conformation [51-55] followed by [5-51]. The formation of
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[14-38] was observed at about 2 ns.

During the process, Cys5-Cys55 and

Cys14-Cys38 distances were decreased and then increased multiple times which
helped to compact the structure and proceed towards the native like
conformation. The Cys5 and Cys38 were seen very close at around 8.5 ns. The
[5-30] non-native intermediate rearranges and compacts the structure of protein
by forming native like two-disulfide intermediate N* at about 12.5 ns which further
rearranges to another native like two-disulfide intermediate NSH transiently.
The very native like conformation NSH has Cys5-Cys55 and Cys30-Cys51
in the close proximity. The Cys14-Cys38 distance decreased immediately leading
to native structure. In the present simulation, N* was formed and rearranged to
NSH. Here too, Cys14-Cys38 distance was decreased after the formation of NSH
which is important in the folding process of BPTI. Our finding from simulation is
very close to the experimental findings.
5.4.2.5 Analysis of trajectories
The folding proceeded via the complete unfolding followed by immediate
formation of non-native [51-55] intermediate which rearranged back to [5-55] but
with different conformation which then rearranged to [14-38] intermediate. The
Cys5-Cys55 and Cys14-Cys38 distances were decreasing and then increasing
multiple times while the conformation is changing more towards the native one.
Another single disulfide containing non-native intermediate [5-30] was observed
which rearranged to N*. The N* intermediate was then rearranged to NSH. The
decrease in Cys14-Cys38 distance was then observed bringing the stable
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conformation of native BPTI. The pathway of transformation depicted in Figure
5.14 showing the intermediate structures.
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Figure 5.13 Folding trajectories demonstrating the BPTI folding pathway from [555] conformation to folded native state. The curve shows the decrease in the
radius of gyration (Rg) with respect to folding time. Some of the conformations of
trajectory (a-j) were shown to show how Rg decreases along with the progress of
folding.
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Figure 5.14 Snapshots of different conformations formed during TMD simulation
of [5-55] like conformation of BPTI to native like BPTI. Sulfur atoms of cysteines
are shown as yellow balls.
5.5 Conclusion
The actual disulfide bonds were made absent during the preparation of
input files for simulation for targeted MD. The role of disulfide bond in very
important for the folding of BPTI resulting in the much better approach for the
final native structure. Targeted MD was run for single domain for 15 ns. The
presented TMD simulations were focused on orientation of cysteine residue for
disulfide bond formation as a result of the conformational changes during the
folding process. The formation of stable native structure at the end of simulation
without the involvement of actual disulfide bonds in simulation proves that our
model can be used for the study of conformational folding mechanism of disulfide
containing protein. The variations of the radius of gyration (Rg) along with the
folding trajectories analyzed to investigate the pathway of BPTI folding.
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CHAPTER 6
Conclusion
Folding of reduced BPTI was investigated oxidatively using three different
aromatic thiols and their corresponding disulfides namely PA, SA, and QAS. The
effect of charge(s) of the side chain group was also studied. The optimal folding
condition using a redox buffer composed of QAS thiol and its disulfide was
determined by plotting a graph of percentage of native protein formed versus
refolding time for every condition selected and then comparing the graphs.
Hence, an efficient folding method of reduced BPTI was determined and
compared with the previously published results using GSH/GSSG. In best
condition, the native form of BPTI was produced in over 90% yield in less than an
hour while using GSH/GSSG under optimal condition, took 2 days to produce
over 90% native protein.
As folding was most efficient using QAS thiol and its corresponding
disulfide, it was sought to prepare different QAS thiols with more hydrophobic
groups for further study. Three different QAS thiols (2, 3, and 4) and their
corresponding disulfides (6, 7, and 8) were successfully prepared. The purity of
these compounds was determined by nuclear magnetic spectroscopy and HPLC.
The folding of reduced BPTI was also studied by taking advantage of
sophisticated computational programming methods developed to study molecular
dynamics. Targeted molecular dynamics was used for our folding study. The
folding process was studied in two different ways. In one method, all atoms of the
initial structure were targeted to the target structure. It was seen that the correct
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antiparallel β-sheets formation is required to form the (14-38) disulfide bond. The
formation of N' [30-51; 14-38] and N* [5-55; 14-38] intermediates were not
observed. The [5-55] intermediate rearranged to NSH [5-55; 30-51] after a series
of thiol-disulfide interchange process simultaneously with the conformational
folding. Almost at the end of simulation, flipping of one β-sheet allowed the
protein to form NSH which immediately transformed to native protein as the (1438) disulfide bond was formed. In other method, only the α-carbons and sulfur
atoms of the cysteine residues (SG) were targeted to the target structure. The
study showed the formation and breaking of (14-38) bonds multiple times. The
formation of native intermediate N* [5-55; 14-38] was observed followed by the
formation of NSH [5-55; 30-51] transiently, which was transformed to native
structure immediately. It was concluded from both of our studies that,
conformational changes in the intermediate formed plays a crucial role to form
disulfide bonds.
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CHAPTER 7
Future Works
Folding of BPTI was very successful using both experimental and
computational methods. To further improve the folding rate and yield, the use of
redox buffer made up of more hydrophobic QAS thiols 2, 3, and 4 and their
corresponding disulfides 6, 7 and 8 is proposed. As the hydrophobicity increases,
the pKa value decreases. It is expected that the pKa of these QAS thiols will be
close to 7 hence folding will go more smoothly forming less intermediates. It is
also expected that the yield will also increase even though the folding will go at a
slower rate.
The use of different computational methods is also proposed to investigate
the folding process of reduced BPTI. Use of different shaped random structures
of reduced BPTI and run simulations using different molecular dynamics is also
suggested. One can mimic the oxidative folding conditions using computer
programming so that better insight on the folding process can be found which will
help experimentalists to think about setting up experiments in a different way.
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